After completing neurology training at the Royal Brisbane & Women’s Hospital(RBWH) in 1995, A/Prof O’Sullivan completed Fellowships in Movement Disorders at the Austin & Repatriation Medical Centre, Melbourne then the National Hospital for Neurology and Neurosurgery, and Middlesex Hospital in London, UK. He was awarded a doctorate in Medicine from Melbourne University in 2000 for studies into surgery for Parkinson’s disease. He returned to the RBWH in 2001 and set up the Movement Disorders Clinical Service including botulinum toxin and later Friedreich's ataxia clinics, and co-ordinating the Huntington's disease multidisciplinary clinic. Through these clinics he has established collaborations with local, interstate and international researchers in the fields of Parkinson's disease, and other movement disorders and neurodegenerative diseases. He is currently Associate Professor of Medicine and Principal Research Fellow at UQ Centre for Clinical Research, previously Royal Brisbane and Uniting Care Health Clinical Units in UQ School of Clinical Medicine. A/Prof O'Sullivan past President of the Movement Disorders Society of Australia and New Zealand (MDSANZ), having previously served as Chair of the MDSANZ Clinical Trials and Research Group. He is on the Council of the Australian and New Zealand Association of Neurolgists (ANZAN) and previously chaired the ANZAN Scientific Program Committee
A/Prof O’Sullivan’s novel investigator-initiated clinical trial in Parkinson’s disease (PD) (Mov Dis 2007; 22:1543-9) is cited in the American Academy of Neurology Practice Parameters and MDS Evidence Based Medicine Review of Management of Non-motor symptoms in PD. The initial description of syndrome of Dopamine Dysregulation in PD (JNNP 2000; 68:423-428) complicating dopamine replacement therapy in some patients with Parkinson’s disease has led to widespread recognition of the syndrome, and this paper has had more than 400 citations. The Movement Disorders Society revision of the Unified Parkinson’s Disease Rating Scale (MDS–UPDRS) includes a section to address features of the dopamine dysregulation syndrome as a result of this. This research has also contributed to debate about addiction in general (Addiction. 2012;107(2):253).
Journal Article: Feasibility and acceptability of a videoconferencing CBT intervention for anxiety in people with Parkinson’s Disease
Roper, Amy, Brooks, Deborah, Mitchell, Leander K., Pachana, Nancy A., Au, Tiffany R., Byrne, Gerard J., O’Sullivan, John D. and Dissanayaka, Nadeeka N. (2024). Feasibility and acceptability of a videoconferencing CBT intervention for anxiety in people with Parkinson’s Disease. Clinical Gerontologist, 1-16. doi: 10.1080/07317115.2024.2306861
Journal Article: Levetiracetam for the treatment of mild cognitive impairment in Parkinson's disease: a double-blind controlled proof-of-concept trial protocol
Dissanayaka, Nadeeka, Pourzinal, Dana, Byrne, Gerard J., Yang, Jihyun, McMahon, Katie L., Pontone, Gregory M., O'Sullivan, John D., Adam, Robert, Littleford, Roberta, Chatfield, Mark, Lehn, Alexander, Mari, Zoltan and Bakker, Arnold (2023). Levetiracetam for the treatment of mild cognitive impairment in Parkinson's disease: a double-blind controlled proof-of-concept trial protocol. Pilot and Feasibility Studies, 9 (1) 189, 189. doi: 10.1186/s40814-023-01406-y
Journal Article: Pareidolias are a function of visuoperceptual impairment
McCann, Emily, Lee, Soohyun, Coleman, Felicia, O’Sullivan, John D. and Nestor, Peter J. (2023). Pareidolias are a function of visuoperceptual impairment. PLoS One, 18 (11) e0293942, 1-11. doi: 10.1371/journal.pone.0293942
(2023–2027) NHMRC MRFF Dementia, Ageing and Aged Care Mission
(2023–2026) Huntington's Australia Research Grant
Mining the gut microbiome to develop new treatments and biomarkers for Parkinson's disease
(2023–2025) Wesley Medical Research Ltd
The evolution of cognitive deficits in Lewy body disorders and related degenerative diseases.
Doctor Philosophy
(2023) Doctor Philosophy
Depression in Parkinson's disease: assessment methods and risk factors
(2008) Doctor Philosophy
Roper, Amy, Brooks, Deborah, Mitchell, Leander K., Pachana, Nancy A., Au, Tiffany R., Byrne, Gerard J., O’Sullivan, John D. and Dissanayaka, Nadeeka N. (2024). Feasibility and acceptability of a videoconferencing CBT intervention for anxiety in people with Parkinson’s Disease. Clinical Gerontologist, 1-16. doi: 10.1080/07317115.2024.2306861
Dissanayaka, Nadeeka, Pourzinal, Dana, Byrne, Gerard J., Yang, Jihyun, McMahon, Katie L., Pontone, Gregory M., O'Sullivan, John D., Adam, Robert, Littleford, Roberta, Chatfield, Mark, Lehn, Alexander, Mari, Zoltan and Bakker, Arnold (2023). Levetiracetam for the treatment of mild cognitive impairment in Parkinson's disease: a double-blind controlled proof-of-concept trial protocol. Pilot and Feasibility Studies, 9 (1) 189, 189. doi: 10.1186/s40814-023-01406-y
Pareidolias are a function of visuoperceptual impairment
McCann, Emily, Lee, Soohyun, Coleman, Felicia, O’Sullivan, John D. and Nestor, Peter J. (2023). Pareidolias are a function of visuoperceptual impairment. PLoS One, 18 (11) e0293942, 1-11. doi: 10.1371/journal.pone.0293942
Longitudinal follow up of data‐driven cognitive subtypes in Parkinson's disease
Pourzinal, Dana, Yang, Jihyun, Sivakumaran, Kumareshan, McMahon, Katie L., Mitchell, Leander, O'Sullivan, John D., Byrne, Gerard J. and Dissanayaka, Nadeeka N. (2023). Longitudinal follow up of data‐driven cognitive subtypes in Parkinson's disease. Brain and Behavior, 13 (10) e3218, e3218. doi: 10.1002/brb3.3218
Yang, Jihyun, Pourzinal, Dana, Byrne, Gerard J., McMahon, Katie L., Copland, David A., O’Sullivan, John D., Mitchell, Leander and Dissanayaka, Nadeeka N. (2023). Global assessment, cognitive profile, and characteristics of mild cognitive impairment in Parkinson's disease. International Journal of Geriatric Psychiatry, 38 (6) e5955, e5955. doi: 10.1002/gps.5955
Jayabalan, Nanthini, Oronsky, Bryan, Cabrales, Pedro, Reid, Tony, Caroen, Scott, Johnson, Aishwarya M., Birch, Natalia A., O’Sullivan, John D. and Gordon, Richard (2023). A review of RRx-001: a late-stage multi-indication inhibitor of NLRP3 activation and chronic inflammation. Drugs, 83 (5), 389-402. doi: 10.1007/s40265-023-01838-z
Yang, Jihyun, McMahon, Katie L., Copland, David A., Pourzinal, Dana, Byrne, Gerard J., Angwin, Anthony J., O’Sullivan, John D. and Dissanayaka, Nadeeka N (2022). Semantic fluency deficits and associated brain activity in Parkinson’s disease with mild cognitive impairment. Brain Imaging and Behavior, 16 (6), 1-12. doi: 10.1007/s11682-022-00698-7
Jewell, Shannon, Roper, Kerry, Woodhouse, Helen, Adam, Robert, O'Sullivan, John and Gordon, Richard (2022). LC-MS based urine metabolomic profiling indicate altered gut microbiome and host lipid metabolites in Parkinson's disease. The FASEB Journal, 36 (S1). doi: 10.1096/fasebj.2022.36.S1.R2928
Caring for a loved one with Parkinson’s disease: the role of coping styles and relationship quality
Zhang, Angeline, Mitchell, Leander K., Pachana, Nancy A., Yang, Ji Hyun J., Au, Tiffany R., Byrne, Gerard J., O’Sullivan, John D. and Dissanayaka, Nadeeka N. (2022). Caring for a loved one with Parkinson’s disease: the role of coping styles and relationship quality. International Psychogeriatrics, 34 (7), 1-8. doi: 10.1017/s1041610221002866
Vivash, Lucy, Bertram, Kelly L, Malpas, Charles B, Marotta, Cassandra, Harding, Ian H, Kolbe, Scott, Fielding, Joanne, Clough, Meaghan, Lewis, Simon J G, Tisch, Stephen, Evans, Andrew H, O'Sullivan, John D, Kimber, Thomas, Darby, David, Churilov, Leonid, Law, Meng, Hovens, Christopher M, Velakoulis, Dennis and O'Brien, Terence J (2021). Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: Protocol for a phase 2, randomised, double-blind, placebo-controlled trial. BMJ Open, 11 (12) e055019, e055019. doi: 10.1136/bmjopen-2021-055019
Dissanayaka, Nadeeka N., Forbes, Elana J., Yang, Ji Hyun J., Pourzinal, Dana, O’Sullivan, John D., Mitchell, Leander K., Copland, David A., McMahon, Katie L. and Byrne, Gerard J. (2021). Anxiety disorders are associated with verbal memory impairment in patients with Parkinson’s disease without dementia. Journal of Neurology, 269 (3), 1600-1609. doi: 10.1007/s00415-021-10736-x
Defining atypical anxiety in Parkinson's disease
Forbes, Elana J., Byrne, Gerard J., O'Sullivan, John D., Yang, Jihyun, Marsh, Rodney and Dissanayaka, Nadeeka N. (2021). Defining atypical anxiety in Parkinson's disease. Movement Disorders Clinical Practice, 8 (4), 571-581. doi: 10.1002/mdc3.13193
Yang, Jihyun, Pourzinal, Dana, McMahon, Katie L., Byrne, Gerard J., Copland, David A., O’Sullivan, John D. and Dissanayaka, Nadeeka N. (2021). Neural correlates of attentional deficits in Parkinson’s disease patients with mild cognitive impairment. Parkinsonism and Related Disorders, 85, 17-22. doi: 10.1016/j.parkreldis.2021.02.009
Evans, Andrew, Fung, Victor S. C., O'Sullivan, John D., Stell, Rick, White, Richard, Williams, David R., Femia, Samira and Onuk, Koray (2021). Characteristics of advanced Parkinson's disease patients seen in movement disorder clinics - Australian results from the cross-sectional OBSERVE study. Clinical Parkinsonism and Related Disorders, 4 100075, 100075. doi: 10.1016/j.prdoa.2020.100075
Differential patterns of internally generated responses in parkinsonian disorders
Tjokrowijoto, Priscilla, Ceslis, Amelia, O'Sullivan, John D., Adam, Robert, Mellick, George, Silburn, Peter and Robinson, Gail A. (2020). Differential patterns of internally generated responses in parkinsonian disorders. Neuropsychologia, 146 107569, 107569. doi: 10.1016/j.neuropsychologia.2020.107569
Identifying subtypes of mild cognitive impairment in Parkinson’s disease using cluster analysis
Pourzinal, Dana, Yang, Ji Hyun J., Byrne, Gerard J., O’Sullivan, John D., Mitchell, Leander, McMahon, Katie L., Copland, David A. and Dissanayaka, Nadeeka N. (2020). Identifying subtypes of mild cognitive impairment in Parkinson’s disease using cluster analysis. Journal of Neurology, 267 (11), 3213-3222. doi: 10.1007/s00415-020-09977-z
O'Sullivan, John D (2020). Too much of a good thing: hedonistic homoeostatic dysregulation and other behavioural consequences of excessive dopamine replacement therapy in Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 91 (6), 566-567. doi: 10.1136/jnnp-2019-322378
Nikles, J., O'Sullivan, J. D., Mitchell, G. K., Smith, S. S., McGree, J. M., Senior, H., Dissanyaka, N. and Ritchie, A. (2019). Protocol: using N-of-1 tests to identify responders to melatonin for sleep disturbance in Parkinson's disease. Contemporary Clinical Trials Communications, 15 100397, 100397. doi: 10.1016/j.conctc.2019.100397
Updates and advances in the treatment of Parkinson disease
Hayes, Michael W., Fung, Victor S. C., Kimber, Thomas E. and O'Sullivan, John D. (2019). Updates and advances in the treatment of Parkinson disease. Medical Journal of Australia, 211 (6), 277-283. doi: 10.5694/mja2.50224
Marsh, Rodney, Cole, Michael H., Dissanayaka, Nadeeka N. W., Au, Tiffany R., Clewett, Sandra, O’Sullivan, John D. and Silburn, Peter A. (2019). The CuePed Trial: how does environmental complexity impact cue effectiveness? A comparison of tonic and phasic visual cueing in simple and complex environments in a Parkinson’s Disease population with freezing of gait. Parkinson's Disease, 2019 2478980, 1-6. doi: 10.1155/2019/2478980
Madden, Daniel L., Sale, Martin V., O'Sullivan, John and Robinson, Gail A. (2019). Improved language production with transcranial direct current stimulation in progressive supranuclear palsy. Neuropsychologia, 127, 148-157. doi: 10.1016/j.neuropsychologia.2019.02.022
Dissanayaka, Nadeeka N.W., Au, Tiffany R., Angwin, Anthony J., Iyer, Kartik K., O'Sullivan, John D., Byrne, Gerard J., Silburn, Peter A., Marsh, Rodney, Mellick, George D. and Copland, David A. (2019). Depression symptomatology correlates with event-related potentials in Parkinson's disease: an affective priming study. Journal of Affective Disorders, 245, 897-904. doi: 10.1016/j.jad.2018.11.094
A novel Parkinson's disease risk variant, p. W378R, in the Gaucher's disease GBA gene
Lubomski, Michal, Hayes, Michael, Kennerson, Marina, Ellis, Melina, Chu, Shannon, Blackie, Jeffrey, O'Sullivan, John D. and Nicholson, Garth (2018). A novel Parkinson's disease risk variant, p. W378R, in the Gaucher's disease GBA gene. Movement Disorders, 33 (10), 1662-1664. doi: 10.1002/mds.106
Energization and spoken language production: evidence from progressive supranuclear palsy
Barker, Megan S., Nelson, Nicole L., O'Sullivan, John D., Adam, Robert and Robinson, Gail A. (2018). Energization and spoken language production: evidence from progressive supranuclear palsy. Neuropsychologia, 119, 349-362. doi: 10.1016/j.neuropsychologia.2018.09.004
An overview of sleep and circadian dysfunction in Parkinson's disease
Mantovani, Susanna, Smith, Simon S., Gordon, Richard and O'Sullivan, John D. (2018). An overview of sleep and circadian dysfunction in Parkinson's disease. Journal of Sleep Research, 27 (3) e12673, e12673. doi: 10.1111/jsr.12673
How well do caregivers detect depression and anxiety in patients with Parkinson disease?
Kua, Zhong Jie, Pachana, Nancy A., Byrne, Gerard J., O’Sullivan, John D., Rodney, Marsh, Torbey, Elizabeth, Silburn, Peter A., Mellick, George D. and Dissanayaka, Nadeeka N. W. (2018). How well do caregivers detect depression and anxiety in patients with Parkinson disease?. Journal of Geriatric Psychiatry and Neurology, 31 (5), 089198871878864-236. doi: 10.1177/0891988718788641
Stepwise partitioning of Xp21: a profiling method for XK deletions causative of the McLeod syndrome
Gassner, Christoph, Brönnimann, Chantal, Merki, Yvonne, Mattle-Greminger, Maja P., Sigurdardottir, Sonja, Meyer, Eduardo, Engström, Charlotte, O'Sullivan, John D., Jung, Hans H. and Frey, Beat M. (2017). Stepwise partitioning of Xp21: a profiling method for XK deletions causative of the McLeod syndrome. Transfusion, 57 (9), 2125-2135. doi: 10.1111/trf.14172
N400 and emotional word processing in Parkinson's disease
Dissanayaka, Nadeeka N. W., Au, Tiffany R., Angwin, Anthony J., O’Sullivan, John D., Byrne, Gerard J., Silburn, Peter A., Rodney Marsh, Mellick, George D. and Copland, David A. (2017). N400 and emotional word processing in Parkinson's disease. Neuropsychology, 31 (6), 585-595. doi: 10.1037/neu0000333
Practical approaches to commencing device-assisted therapies for Parkinson's disease in Australia
Williams, David R., Evans, Andrew H., Fung, Victor S., Hayes, Michael, Iansek, Robert, Kimber, Thomas, O'Sullivan, John D. and Sue, Carolyn M. (2017). Practical approaches to commencing device-assisted therapies for Parkinson's disease in Australia. Internal Medicine Journal, 47 (10), 1107-1113. doi: 10.1111/imj.13398
Cognitive behavior therapy for anxiety in Parkinson’s disease: outcomes for patients and caregivers
Dissanayaka, Nadeeka N. W., Pye, Deidre, Mitchell, Leander K., Byrne, Gerard J., O'Sullivan, John D., Marsh, Rodney and Pachana, Nancy A. (2016). Cognitive behavior therapy for anxiety in Parkinson’s disease: outcomes for patients and caregivers. Clinical Gerontologist, 40 (3), 159-171. doi: 10.1080/07317115.2016.1240131
Management of impulse control disorders in Parkinson's disease
Zhang, Susan, Dissanayaka, Nadeeka N., Dawson, Andrew, O’Sullivan, John D., Mosley, Philip, Hall, Wayne and Carter, Adrian (2016). Management of impulse control disorders in Parkinson's disease. International Psychogeriatrics, 28 (10), 1597-1614. doi: 10.1017/S104161021600096X
Disease-specific anxiety symptomatology in Parkinson's disease
Dissanayaka, Nadeeka N. W., O'Sullivan, John D., Pachana, Nancy A., Marsh, Rodney, Silburn, Peter A., White, Elizabeth X., Torbey, Elizabeth, Mellick, George D., Copland, David A. and Byrne, Gerard J. (2016). Disease-specific anxiety symptomatology in Parkinson's disease. International Psychogeriatrics, 28 (7), 1-11. doi: 10.1017/S1041610215002410
Mindfulness for motor and nonmotor dysfunctions in Parkinson’s Disease
Dissanayaka, Nadeeka N. W., Idu Jion, Farah, Pachana, Nancy A., O'Sullivan, John D., Marsh, Rodney, Byrne, Gerard J. and Harnett, Paul (2016). Mindfulness for motor and nonmotor dysfunctions in Parkinson’s Disease. Parkinson’s Disease, 2016 7109052, 7109052.1-7109052.13. doi: 10.1155/2016/7109052
Ngo, S. T., Steyn, F. J., Huang, L., Mantovani, S., Pfluger, C. M. M., Woodruff, T. M., O'Sullivan, J. D., Henderson, R. D. and McCombe, P. A. (2015). Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 357 (1-2), 22-27. doi: 10.1016/j.jns.2015.06.053
Trenkwalder, Claudia., Chaudhuri, K. Ray., Garcia Ruiz, Pedro J., LeWitt, Peter., Katzenschlager, Regina., Sixel-Doring, Friederike., Henriksen, Tove., Sesar, Angel., Poewe, Werner., Baker, Mary., Ceballos-Baumann, Andres., Gunther, Deuschl., Drapier, Sophie., Ebersbach, Georg., Evans, Andrew., Fernandez, Hubert., Isaacson, Stuart., van Laar, Teus., Lees, Andrew., Lewis, Simon., Castrillo, Juan Carlos Martinez., Martinez-Martin, Pablo., Odin, Per., O'Sullivan, John., Tagaris, Georgios. and Wenzel, Karoline. (2015). Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease - Clinical practice recommendations. Parkinsonism and Related Disorders, 21 (9), 1023-1030. doi: 10.1016/j.parkreldis.2015.06.012
Characteristics and Treatment of Anxiety Disorders in Parkinson's Disease
Dissanayaka, Nadeeka N. W., White, Elizabeth, O'Sullivan, John D., Marsh, Rodney, Silburn, Peter A., Copland, David A., Mellick, George D. and Byrne, Gerard J. (2015). Characteristics and Treatment of Anxiety Disorders in Parkinson's Disease. Movement Disorders Clinical Practice, 2 (2), 155-162. doi: 10.1002/mdc3.12157
Vertebrobasilar dissections: case series comparing patients with and without dissecting aneurysms
Badve, Monica S., Henderson, Robert D., O'Sullivan, John D., Wong, Andrew A., Mitchell, Ken, Coulthard, Alan and Read, Stephen J. (2014). Vertebrobasilar dissections: case series comparing patients with and without dissecting aneurysms. Journal of Clinical Neuroscience, 21 (11), 2028-2030. doi: 10.1016/j.jocn.2014.02.015
The clinical spectrum of anxiety in Parkinson's disease
Dissanayaka, Nadeeka N. N. W., White, Elizabeth, O'Sullivan, John D., Marsh, Rodney, Pachana, Nancy A. and Byrne, Gerard J. (2014). The clinical spectrum of anxiety in Parkinson's disease. Movement Disorders, 29 (8), 967-975. doi: 10.1002/mds.25937
Deep Brain Stimulation for DYT3 Dystonia
Lehn, Alexander, Airey, Caroline, Olson, Sarah, O'Sullivan, John D. and Boyle, Richard (2014). Deep Brain Stimulation for DYT3 Dystonia. Movement Disorders Clinical Practice, 1 (1), 73-75. doi: 10.1002/mdc3.12017
Risk factors for idiopathic dystonia in Queensland, Australia
Newman, Jeremy R. B., Boyle, Richard S., O'Sullivan, John D., Silburn, Peter A. and Mellick, George D. (2014). Risk factors for idiopathic dystonia in Queensland, Australia. Journal of Clinical Neuroscience, 21 (12), 2145-2149. doi: 10.1016/j.jocn.2014.03.032
Cordell, Heather J., Bentham, Jamie, Topf, Ana, Zelenika, Diana, Heath, Simon, Mamasoula, Chrysovalanto, Cosgrove, Catherine, Blue, Gillian, Granados-Riveron, Javier, Setchfield, Kerry, Thornborough, Chris, Breckpot, Jeroen, Soemedi, Rachel, Martin, Ruairidh, Rahman, Thahira J., Hall, Darroch, Van Engelen, Klaartje, Moorman, Antoon F.M., Zwinderman, Aelko H., Barnett, Phil, Koopmann, Tamara T., Adriaens, Michiel E., Varro, Andras, George Jr., Alfred L., Dos Remedios, Christobal, Bishopric, Nanette H., Bezzina, Connie R., O'Sullivan, John, Gewillig, Marc ... Keavney, Bernard D. (2013). Genome-wide association study of multiple congenital heart disease phenotypes identifies a susceptibility locus for atrial septal defect at chromosome 4p16. Nature Genetics, 45 (7), 822-824. doi: 10.1038/ng.2637
'North Sea' progressive myoclonus epilepsy: phenotype of subjects with GOSR2 mutation
Lomax, Lysa Boisse, Bayly, Marta A., Hjalgrim, Helle, Moller, Rikke S., Vlaar, Annemarie M., Aaberg, Kari M., Marquardt, Iris, Gandolfo, Luke C., Willemsen, Michel, Kamsteeg, Erik-Jan, O'Sullivan, John D., Korenke, G. Christoph, Bloem, Bastiaan R., de Coo, Irenaeus F., Verhagen, Judith M. A., Said, Ines, Prescott, Trine, Stray-Pedersen, Asbjorg, Rasmussen, Magnhild, Vears, Danya F., Lehesjoki, Anna-Elina, Corbett, Mark A., Bahlo, Melanie, Gecz, Jozef, Dibbens, Leanne M. and Berkovic, Samuel F. (2013). 'North Sea' progressive myoclonus epilepsy: phenotype of subjects with GOSR2 mutation. Brain, 136 (4), 1146-1154. doi: 10.1093/brain/awt021
Long term language recovery subsequent to low frequency rTMS in chronic non-fluent aphasia
Barwood, Caroline H. S., Murdoch, Bruce E., Riek, Stephan, O'Sullivan, John D., Wong, Andrew, Lloyd, David and Coulthard, Alan (2013). Long term language recovery subsequent to low frequency rTMS in chronic non-fluent aphasia. Neurorehabilitation, 32 (4), 915-928. doi: 10.3233/NRE-130915
Nguyen, Giang Truong, Coulthard, Alan, Wong, Andrew, Sheikh, Nabeel, Henderson, Robert, O'Sullivan, John D. and Reutens, David C. (2013). Measurement of blood-brain barrier permeability in acute ischemic stroke using standard first-pass perfusion CT data. NeuroImage: Clinical, 2 (1), 658-662. doi: 10.1016/j.nicl.2013.04.004
Contribution of global rare copy-number variants to the risk of sporadic congenital heart disease
Soemedi, Rachel, Wilson, Ian J., Bentham, Jamie, Darlay, Rebecca, Töpf, Ana, Zelenika, Diana, Cosgrove, Catherine, Setchfield, Kerry, Thornborough, Chris, Granados-Riveron, Javier, Blue, Gillian M., Breckpot, Jeroen, Hellens, Stephen, Zwolinkski, Simon, Glen, Elise, Mamasoula, Chrysovalanto, Rahman, Thahira J., Hall, Darroch, Rauch, Anita, Devriendt, Koenraad, Gewillig, Marc, O'sullivan, John, Winlaw, David S., Bu'lock, Frances, Brook, J. David, Bhattacharya, Shoumo, Lathrop, Mark, Santibanez-Koref, Mauro, Cordell, Heather J. ... Keavney, Bernard D. (2012). Contribution of global rare copy-number variants to the risk of sporadic congenital heart disease. American Journal of Human Genetics, 91 (3), 489-501. doi: 10.1016/j.ajhg.2012.08.003
Barwood, Caroline H. S., Murdoch, Bruce E., Whelan, Brooke-Mai, Lloyd, David, Riek, Stephan, O’Sullivan, John D., Coulthard, Alan and Wong, Andrew (2012). Improved receptive and expressive language abilities in nonfluent aphasic stroke patients after application of rTMS: an open protocol case series. Brain Stimulation, 54 (3), 274-286. doi: 10.1016/j.brs.2011.03.005
Common polymorphisms in dystonia-linked genes and susceptibility to the sporadic primary dystonias
Newman, Jeremy R. B., Sutherland, Greg T., Boyle, Richard S., Limberg, Nicole, Blum, Stefan, O'Sullivan, John D., Silburn, Peter A. and Mellick, George D. (2012). Common polymorphisms in dystonia-linked genes and susceptibility to the sporadic primary dystonias. Parkinsonism & Related Disorders, 18 (4), 351-357. doi: 10.1016/j.parkreldis.2011.11.024
Validity and reliability of the Geriatric Anxiety Inventory in Parkinson's disease
Matheson, Sally F., Byrne, Gerard J., Dissanayaka, Nadeeka N. W., Pachana, Nancy A., Mellick, George D., O'Sullivan, John D., Silburn, Peter A., Sellbach, Anna and Marsh, Rodney (2012). Validity and reliability of the Geriatric Anxiety Inventory in Parkinson's disease. Australasian Journal on Ageing, 31 (1), 13-16. doi: 10.1111/j.1741-6612.2010.00487.x
Frequency and function of regulatory T cells after ischaemic stroke in humans
Yan, Jun, Read, Stephen J., Henderson, Robert D., Hull, Renee, O'Sullivan, John D., McCombe, Pamela A. and Greer, Judith M. (2012). Frequency and function of regulatory T cells after ischaemic stroke in humans. Journal of Neuroimmunology, 243 (1-2), 89-94. doi: 10.1016/j.jneuroim.2011.12.019
Compulsive use of dopamine replacement therapy: a model for stimulant drug addiction?
Ambermoon, Polly, Carter, Adrian, Hall, Wayne, Dissanayaka, Nadeeka and O'Sullivan, John (2012). Compulsive use of dopamine replacement therapy: a model for stimulant drug addiction?. Addiction, 107 (2), 241-247. doi: 10.1111/j.1360-0443.2011.03511.x
Stimulating Debate in the Field of Addiction
Carter, Adrian, Hall, Wayne, Ambermoon, Polly, Dissanayaka, Nadeeka and O'Sullivan, John (2012). Stimulating Debate in the Field of Addiction. Addiction, 107 (2), 253-253. doi: 10.1111/j.1360-0443.2011.03717.x
Barwood, Caroline H. S., Murdoch, Bruce E., Whelan, Brooke-Mai, O'Sullivan, John D., Wong, Andrew, Lloyd, David, Riek, Stephan and Coulthard, Alan (2012). Longitudinal modulation of N400 in chronic non-fluent aphasia using low-frequency rTMS: A randomised placebo controlled trial. Aphasiology, 26 (1), 103-124. doi: 10.1080/02687038.2011.617812
Ischemic stroke and transient ischemic attack after head and neck radiotherapy: a review
Plummer, Chris, Henderson, Robert D., O'Sullivan, John D. and Read, Stephen J. (2011). Ischemic stroke and transient ischemic attack after head and neck radiotherapy: a review. Stroke, 42 (9), 2410-2418. doi: 10.1161/STROKEAHA.111.615203
Factors associated with depression in Parkinson's disease
Dissanayaka, Nadeeka N. W., Sellbach, Anna, Silburn, Peter A., O'Sullivan, John D., Marsh, Rodney and Mellick, George D. (2011). Factors associated with depression in Parkinson's disease. Journal of Affective Disorders, 132 (1-2), 82-88. doi: 10.1016/j.jad.2011.01.021
Barwood, C. H. S., Murdoch, B. E., Whelan, B. -M., Lloyd, D., Riek, S., O'Sullivan, J. D., Coulthard, A. and Wong, A. (2011). Improved language performance subsequent to low-frequency rTMS in patients with chronic non-fluent aphasia post-stroke. European Journal of Neurology, 18 (7), 935-943. doi: 10.1111/j.1468-1331.2010.03284.x
Brauer, Sandra G., Woollacott, Marjorie H., Lamont, Robyn, Clewett, Sandy, O'Sullivan, John, Silburn, Peter, Mellick, George D. and Morris, Meg E. (2011). Single and dual task gait training in people with Parkinson's Disease: A protocol for a randomised controlled trial. BMC Neurology, 11 (1) 90, 1-6. doi: 10.1186/1471-2377-11-90
A mutation in the Golgi Qb-SNARE gene GOSR2 causes progressive myoclonus epilepsy with early ataxia
Corbett, Mark A., Schwake, Michael, Bahlo, Melanie, Dibbens, Leanne M., Lin, Meng, Gandolfo, Luke C., Vears, Danya F., O'Sullivan, John D., Robertson, Thomas, Bayly, Marta A., Gardner, Alison E., Vlaar, Annemarie M., Korenke, G. Christoph, Bloem, Bastiaan R., de Coo, Irenaeus F., Verhagen, Judith M. A., Lehesjoki, Anna-Elina, Gecz, Jozef and Berkovic, Samuel F. (2011). A mutation in the Golgi Qb-SNARE gene GOSR2 causes progressive myoclonus epilepsy with early ataxia. American Journal of Human Genetics, 88 (5), 657-663. doi: 10.1016/j.ajhg.2011.04.011
Singh, P., Yan, J., Hull, R., Read, S., O'Sullivan, J., Henderson, R.D., Rose, S., Greer, J.M. and McCombe, P.A. (2011). Levels of phosphorylated axonal neurofilament subunit H (pNfH) are increased in acute ischemic stroke. Journal of the Neurological Sciences, 304 (1-2), 117-121. doi: 10.1016/j.jns.2011.01.025
Barwood, Caroline H. S., Murdoch, Bruce E., Whelan, Brooke-Mai, Lloyd, David, Riek, Stephan, O'Sullivan, John, Coulthard, Alan, Wong, Andrew, Aitken, Phil and Hall, Graham (2011). The effects of low frequency Repetitive Transcranial Magnetic Stimulation (rTMS) and sham condition rTMS on behavioural language in chronic non-fluent aphasia: Short term outcomes. NeuroRehabilitation, 28 (2), 113-128. doi: 10.3233/NRE-2011-0640
Barwood, Chs, Murdoch, BE, Whelan, BM, Lloyd, D, Riek, S, O'Sullivan, JD, Coulthard, A and Wong, A (2011). Modulation of N400 in chronic non-fluent aphasia using low frequency Repetitive Transcranial Magnetic Stimulation (rTMS). Brain and Language, 116 (3), 125-135. doi: 10.1016/j.bandl.2010.07.004
Ambermoon, Polly, Carter, Adrian, Hall, Wayne D., Dissanayaka, Nadeeka N.W. and O'Sullivan, John D. (2011). Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: Evidence and implications for the addictions field. Addiction, 106 (2), 283-293. doi: 10.1111/j.1360-0443.2010.03218.x
Espay, Alberto J., Paviour, Dominic C., O'Sullivan, John D., Schmidt, Robert E., Revilla, Fredy J. and Metman, Leo Verhagen (2010). Juvenile levodopa-responsive Parkinsonism with early orobuccolingual dyskinesias and cognitive impairment. Movement Disorders, 25 (12), 1860-1867. doi: 10.1002/mds.23194
Snow, Baryy J., Rolfe, Fiona L., Lockhart, Michelle M., Frampton, Christopher M., O'Sullivan, John D., Fung, Victor, Smith, Robin A. J., Murphy, Michael P. and Taylor, Kenneth M. (2010). A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease. Movement Disorders, 25 (11), 1670-1674. doi: 10.1002/mds.23148
Anxiety Disorders in Parkinson's Disease: Prevalence and Risk Factors
Dissanayaka, Nadeeka N. W., Sellbach, Anna, Matheson, Sally, O'Sullivan, John D., Silburn, Peter A., Byrne, Gerard J., Marsh, Rodney and Mellick, George D. (2010). Anxiety Disorders in Parkinson's Disease: Prevalence and Risk Factors. Movement Disorders, 25 (7), 838-845. doi: 10.1002/mds.22833
The effect of ageing on human lymphocyte subsets: comparison of males and females
Yan, Jun, Greer, Judith M., Hull, Renee, O'Sullivan, John D., Henderson, Robert D., Read, Stephen J. and McCombe, Pamela A. (2010). The effect of ageing on human lymphocyte subsets: comparison of males and females. Immunity & Ageing, 7 (4) 1742, 1-10. doi: 10.1186/1742-4933-7-4
Current concepts in the management of Parkinson disease
Hayes, Michael W., Fung, Victor S., Kimber, Thomas E. and O'Sullivan, John D. (2010). Current concepts in the management of Parkinson disease. Medical Journal of Australia, 192 (3), 144-149. doi: 10.5694/j.1326-5377.2010.tb03453.x
Validity of a self-rated method to identify a lifetime history of depression in Parkinson's disease
Dissanayaka, Nadeeka N. W., Sellebach, Annabelle N., Matheson, Sally, Marsh, Rodney, O'Sullivan, John D., Silburn, Peter A., Byrne, Gerard J. and Mellick, George D. (2009). Validity of a self-rated method to identify a lifetime history of depression in Parkinson's disease. Movement Disorders, 24 (16), 2435-2438. doi: 10.1002/mds.22819
Sutherland, GT, Halliday, GM, Silburn, PA, Mastaglia, FL, Rowe, DB, Boyle, RS, O'Sullivan, JD, Ly, T, Wilton, SD and Mellick, GD (2009). Do Polymorphisms in the Familial Parkinsonism Genes Contribute to Risk for Sporadic Parkinson's Disease?. MOVEMENT DISORDERS, 24 (6), 833-838. doi: 10.1002/mds.22214
Haplotype Analysis of the PARK 11 Gene, GIGYF2, in Sporadic Parkinson's Disease
Sutherland, Greg T., Siebert, Gerhard A., Newman, Jeremy R.B., Silburn, Peter A., Boyle, Richard S., O'Sullivan, John D. and Mellick, George D. (2009). Haplotype Analysis of the PARK 11 Gene, GIGYF2, in Sporadic Parkinson's Disease. Movement Disorders, 24 (3), 449-452. doi: 10.1002/mds.22427
Serotonin and dopamine transporter genes do not influence depression in Parkinson's disease
Dissanayaka, Nadeeka N. W., Silburn, Peter A., O'Sullivan, John D. and Mellick, George D. (2009). Serotonin and dopamine transporter genes do not influence depression in Parkinson's disease. Movement Disorders, 24 (1), 111-115. doi: 10.1002/mds.22134
Immune activation in the peripheral blood of patients with acute ischemic stroke
Yan, Jun, Greer, Judith M., Etherington, Kellie, Cadigan, Greg P., Cavanagh, Helen, Henderson, Robert D., O'Sullivan, John D., Pandian, Jeyaraj D., Read, Stephen J. and McCombe, Pamela A. (2009). Immune activation in the peripheral blood of patients with acute ischemic stroke. Journal of Neuroimmunology, 206 (1-2), 112-117. doi: 10.1016/j.jneuroim.2008.11.001
Natural history of blood glucose within the first 48 hours after ischemic stroke
Wong, A. A., Schluter, P. J., Henderson, R. D., O'Sullivan, J. D. and Read, S. J. (2008). Natural history of blood glucose within the first 48 hours after ischemic stroke. Neurology, 70 (13), 1036-1041. doi: 10.1212/01.wnl.0000306635.08410.68
The time course and determinants of blood pressure within the first 48 h after ischemic stroke
Wong, Andrew A., Davis, James P., Schluter, Philip J., Henderson, Robert D., O’Sullivan, John D. and Read, Stephen J. (2007). The time course and determinants of blood pressure within the first 48 h after ischemic stroke. Cerebrovascular Diseases, 24 (5), 426-433. doi: 10.1159/000108432
Pandian, Jeyaraj Durai, Perel, Robert, Henderson, Robert D., O'Sullivan, John D. and Read, Stephen (2007). Unusual triggers for stroke. Journal of Clinical Neuroscience, 14 (8), 786-787. doi: 10.1016/j.jocn.2006.05.012
Schoffer, Kerrie L., Henderson, Robert D., O'Maley, Karen and O'Sullivan, John D. (2007). Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease. Movement Disorders, 22 (11), 1543-1549. doi: 10.1002/mds.21428
Validity of Hamilton Depression Inventory in Parkinson's disease
Dissanayaka, N. N. W., Sellbach, A., Matheson, S., Marsh, R., Silburn, P. A., O'Sullivan, J. D., Byrne, G. J. and Mellick, G. D. (2007). Validity of Hamilton Depression Inventory in Parkinson's disease. Movement Disorders, 22 (3), 399-403. doi: 10.1002/mds.21309
Schoffer, K. L., O'Maley, K. and O'Sullivan, J. D. (2007). Development and utilization of the patient knowledge questionnaire on Botulinum toxin use in movement disorders. Journal of Clinical Neuroscience, 14 (8), 737-741. doi: 10.1016/j.jocn.2006.03.021
The time course and determinants of temperature within the first 48 h after ischaemic stroke
Wong, A. A., Davis, J. P., Schluter, P. J., Henderson, R. D., O'Sullivan, J. D. and Read, S. J. (2007). The time course and determinants of temperature within the first 48 h after ischaemic stroke. Cerebrovascular Diseases, 24 (1), 104-110. doi: 10.1159/000103124
Charles Dickens: The man, medicine, and movement disorders
Schoffer, Kerrie L. and O'Sullivan, John D. (2006). Charles Dickens: The man, medicine, and movement disorders. Journal of Clinical Neuroscience, 13 (9), 898-901. doi: 10.1016/j.jocn.2005.12.035
Congenital disorder of glycosylation type Ia presenting as early-onset cerebellar ataxia in an adult
Schoffer, Kerrie L., O'Sullivan, John D. and McGill, Jim (2006). Congenital disorder of glycosylation type Ia presenting as early-onset cerebellar ataxia in an adult. Movement Disorders, 21 (6), 869-872. doi: 10.1002/mds.20804
Cerebral Vasculitis in Ulcerative Colitis
Pandian, Jeyaraj Durai, Henderson, Robert D., O'Sullivan, John D. and Rajah, Thulasi (2006). Cerebral Vasculitis in Ulcerative Colitis. Archives of Neurology, 63 (5), 780-780. doi: 10.1001/archneur.63.5.780
First case report of X linked dystonia parkinsonism (XDP) or 'lubag' in Australia
Plummer, C, Bradfield, J, Singleton, AB, Hernandez, D, Singleton, AA and O'Sullivan, J (2005). First case report of X linked dystonia parkinsonism (XDP) or 'lubag' in Australia. Journal of Clinical Neuroscience, 12 (8), 945-946. doi: 10.1016/j.jocn.2004.10.012
First case report of X linked dystonia parkinsonism (XDP) or 'lubag' in Australia
Plummer, C., Bradfield, J., Singleton, A. B., Hernandez, D., Singleton, A. A. and O'Sullivan, J. (2005). First case report of X linked dystonia parkinsonism (XDP) or 'lubag' in Australia. Journal of Clinical Neuroscience, 12 (8), 946-947. doi: 10.1016/j.jocn.2004.10.015
Cerebeller vermis hyperdensity on CT scan
Wolski, P., Read, S. J., O'Sullivan, J. D. and Henderson, R. D. (2005). Cerebeller vermis hyperdensity on CT scan. Journal of Clinical Neuroscience, 12 (6), 676-676. doi: 10.1016/j.jocn.2005.03.011
Schoffer, Kerrie L., Patterson, Victor, Read, Stephen J., Henderson, Robert D., Pandian, Jeyaraj D. and O'Sullivan, John D. (2005). Guidelines for filming digital camera video clips for the assessment of gait and movement disorders by teleneurology. Journal of Telemedicine and Telecare, 11 (7), 368-371. doi: 10.1258/135763305774472042
Ring enhancement after hemorrhagic stroke
Wong, A.A., Henderson, R. D., O'Sullivan, J. D., Read, S. J. and Rajah, R.T. (2005). Ring enhancement after hemorrhagic stroke. Archives of Neurology, 61 (11), 1790-1790. doi: 10.1001/archneur.61.11.1790
Teaching people with Parkinson's disease about their medication
O'Maley, Karen, O'Sullivan, John, Wollin, Judy, Barras, Michael and Brammer, Jillian (2005). Teaching people with Parkinson's disease about their medication. Nursing Older People, 17 (1) doi: 10.7748/nop2005.03.17.1.14.c2357
The effect of admission physiological variables on 30 day outcome after stroke
Wong, Andrew A., Davis, James P., Schluter, Philip J., Henderson, Robert D., O'Sullivan, John D. and Read, Stephen J. (2005). The effect of admission physiological variables on 30 day outcome after stroke. Journal of Clinical Neuroscience, 12 (8), 905-910. doi: 10.1016/j.jocn.2004.11.012
Evans, AH, Costa, DC, Gacinovic, S, Katzenschlager, R, O'Sullivan, JD, Heales, S, Lee, P and Lees, AJ (2004). L-Dopa-responsive Parkinson's syndrome in association with phenylketonuria: In vivo dopamine transporter and D2 receptor findings. Movement Disorders, 19 (10), 1232-1236. doi: 10.1002/mds.20146
Impact of premorbid undernutrition on outcome in stroke patients
Davis, James P., Wong, Andrew A., Schluter, Philip J., Henderson, Robert D., OSullivan, John D. and Read, Stephen J. (2004). Impact of premorbid undernutrition on outcome in stroke patients. Stroke, 35 (8), 1930-1934. doi: 10.1161/01.STR.0000135227.10451.c9
Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome
Evans, Andrew H., Katzenschlager, Regina, Paviour, Dominic, O'Sullivan, John D., Appel, Silke, Lawrence, Andrew D. and Lees, Andrew J. (2004). Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Movement Disorders, 19 (4), 397-405. doi: 10.1002/mds.20045
Katzenschlager, R., Costa, D., Gerschlager, W., O'Sullivan, J., Zijlmans, J., Gacinovic, S., Pirker, W., Wills, A., Bhatia, K., Lees, A. J. and Brown, P. (2003). Erratum: [12I]-FP-CIT-SPECT demonstrates dopaminergic deficit in orthostatic tremor (Annals of Neurology (2003) 53 (489-496)). Annals of Neurology, 54 (2) doi: 10.1002/ana.10704
[123I]-FP-CIT-SPECT demonstrates dopaminergic deficit in orthostatic tremor
Katzenschlager, Regina, Costa, Durval, Gerschlager, Willibald, O'Sullivan, John, Zijlmans, Jan, Gacinovic, Svetoslav, Pirker, Walter, Wills, Adrian, Bhatia, Kailash, Lees, Andrew J. and Brown, Peter (2003). [123I]-FP-CIT-SPECT demonstrates dopaminergic deficit in orthostatic tremor. Annals of Neurology, 53 (4), 489-496. doi: 10.1002/ana.10475
Unilateral pallidotomy for Parkinson's disease disrupts ocular fixation
O'Sullivan, JD, Maruff, P, Tyler, P, Peppard, RF, McNeill, P and Currie, J (2003). Unilateral pallidotomy for Parkinson's disease disrupts ocular fixation. Journal of Clinical Neuroscience, 10 (2), 181-185. doi: 10.1016/S0967-5868(02)00125-X
Apomorphine as an alternative to sildenafil in Parkinson's disease
O'Sullivan, JD (2002). Apomorphine as an alternative to sildenafil in Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry, 72 (5), 681-681. doi: 10.1136/jnnp.72.5.681
Bilaterally coherent tremor resembling enhanced physiological tremor: Report of three cases
O'Sullivan, JD, Rothwell, J, Lees, AJ and Brown, P (2002). Bilaterally coherent tremor resembling enhanced physiological tremor: Report of three cases. Movement Disorders, 17 (2), 387-391. doi: 10.1002/mds.10097
Munchau, A, Palmer, JD, Dressler, D, O'Sullivan, JD, Tsang, KL, Jahanshahi, M, Quinn, NP, Lees, AJ and Bhatia, KP (2001). Prospective study of selective peripheral denervation for botulinum-toxin resistant patients with cervical dystonia. Brain, 124 (4), 769-783. doi: 10.1093/brain/124.4.769
Motor imagery in Parkinson's disease: A PET study
Cunnington, R, Egan, GF, OSullivan, JD, Hughes, AJ, Bradshaw, JL and Colebatch, JG (2001). Motor imagery in Parkinson's disease: A PET study. Movement Disorders, 16 (5), 849-857. doi: 10.1002/mds.1181
SPECT imaging of the dopamine transporter in juvenile-onset dystonia
O'Sullivan, JD, Costa, DC, Gacinovic, S and Lees, AJ (2001). SPECT imaging of the dopamine transporter in juvenile-onset dystonia. Neurology, 56 (2), 266-267. doi: 10.1212/WNL.56.2.266
Unusual tremor associated with a posterolateral thalamic lesion in a drummer
O'Sullivan, JD, Brown, P and Lees, AJ (2001). Unusual tremor associated with a posterolateral thalamic lesion in a drummer. Movement Disorders, 16 (1), 174-176. doi: 10.1002/1531-8257(200101)16:1<174::AID-MDS1034>3.0.CO;2-I
O'Sullivan, John D. and Lees, Andrew J. (2000). Nonparkinsonian tremors. Clinical Neuropharmacology, 23 (5), 233-238. doi: 10.1097/00002826-200009000-00001
L-dopa-resistant parkinsonism syndrome following cerebral radiation therapy for neoplasm
Wick, W, Hochberg, F, O'Sullivan, J, Goessling, A, Hughes, A and Cher, L (2000). L-dopa-resistant parkinsonism syndrome following cerebral radiation therapy for neoplasm. Oncology Reports, 7 (6), 1367-1370.
Parkinsonism in HIV encephalopathy
O'Sullivan, John D., Hanagasi, Hasmet A., Daniel, Susan E., Tidswell, Phillip, Davies, Stephen W. and Lees, Andrew J. (2000). Parkinsonism in HIV encephalopathy. Movement Disorders, 15 (5), 1032-1033. doi: 10.1002/1531-8257(200009)15:5<1032::AID-MDS1049>3.0.CO;2-X
Giovannoni, G, O'Sullivan, JD, Turner, K, Manson, AJ and Lees, AJL (2000). Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. Journal of Neurology Neurosurgery and Psychiatry, 68 (4), 423-428. doi: 10.1136/jnnp.68.4.423
An ambulatory dyskinesia monitor
Manson, AJ, Brown, P, O'Sullivan, JD, Asselman, P, Buckwell, D and Lees, AJ (2000). An ambulatory dyskinesia monitor. Journal of Neurology Neurosurgery and Psychiatry, 68 (2), 196-201. doi: 10.1136/jnnp.68.2.196
Botulinum toxin A as treatment for drooling saliva in PD [7] (multiple letters)
O'Sullivan, John D., Bhatia, Kailash P. and Lees, Andrew J. (2000). Botulinum toxin A as treatment for drooling saliva in PD [7] (multiple letters). Neurology, 55 (4), 606-607. doi: 10.1212/WNL.55.4.606-a
Use of apomorphine in Parkinson's disease
O'Sullivan, JD and Lees, AJ (1999). Use of apomorphine in Parkinson's disease. Hospital Medicine, 60 (11), 816-820. doi: 10.12968/hosp.1999.60.11.1236
Oral dopamine agonists adverse drug reaction profile
O'Sullivan, J. and Lees, A. (1999). Oral dopamine agonists adverse drug reaction profile. Prescribers' Journal, 39 (3), 166-172.
Yawning in Parkinson's disease [1] (multiple letters)
Colosimo, C., Pontieri, F. E., Evidente, V. G.H., Hardy, K. G., O'Sullivan, J. D., Lees, A. J., Hughes, A. J., Friedman, J. H. and Goren, J. (1999). Yawning in Parkinson's disease [1] (multiple letters). Neurology, 52 (2), 428-428. doi: 10.1212/WNL.52.2.428
Yawning in Parkinson's disease
O'Sullivan, JD, Lees, AJ and Hughes, AJ (1999). Yawning in Parkinson's disease. Neurology, 52 (2), 428-428.
O'Sullivan, JD, Said, CM, Dillon, LC, Hoffman, M and Hughes, AJ (1998). Gait analysis in patients with Parkinson's disease and motor fluctuations: Influence of levodopa and comparison with other measures of motor function. Movement Disorders, 13 (6), 900-906. doi: 10.1002/mds.870130607
The effect of unilateral posteroventral pallidotomy on the kinematics of the reach to grasp movement
Bennett, KMB, O'Sullivan, JD, Peppard, RF, McNeill, PM and Castiello, U (1998). The effect of unilateral posteroventral pallidotomy on the kinematics of the reach to grasp movement. Journal of Neurology Neurosurgery and Psychiatry, 65 (4), 479-487. doi: 10.1136/jnnp.65.4.479
Apomorphine-induced penile erections in Parkinson's disease
O'Sullivan, JD and Hughes, AJ (1998). Apomorphine-induced penile erections in Parkinson's disease. Movement Disorders, 13 (3), 536-539. doi: 10.1002/mds.870130326
Left posteroventral pallidotomy results in a deficit in verbal memory
Crowe, SF, O'Sullivan, JD, Peppard, RE, McNeill, PM, Bardenhagen, F and Bowden, S. (1998). Left posteroventral pallidotomy results in a deficit in verbal memory. Behavioural Neurology, 11 (2), 79-84. doi: 10.1155/1998/174740
Fatal encephalitis due to novel paramyxovirus transmitted from horses
Osullivan, JD, Allworth, AM, Paterson, DL, Snow, TM, Boots, R, Gleeson, LJ, Gould, AR, Hyatt, AD and Bradfield, J (1997). Fatal encephalitis due to novel paramyxovirus transmitted from horses. Lancet, 349 (9045), 93-95. doi: 10.1016/S0140-6736(96)06162-4
Patterns of antibiotic prescribing in Queensland general practice
Munro, C., Boston, R., Bogiatzis, G., Gibbons, J. and O'Sullivan, J. (1988). Patterns of antibiotic prescribing in Queensland general practice. Australian Family Physician, 17 (12), 1074-1077.
A Novel Role for Glucocerebrosidase 1 (GBA1) in Parkinson's Disease
Jayabalan, Nanthini, Roper, Katherine Kerry, Woodhouse, Helen M., Adam, Robert J., O'Sullivan, John D. and Gordon, Richard (2022). A Novel Role for Glucocerebrosidase 1 (GBA1) in Parkinson's Disease. Experimental Biology Meeting 2022, Philadelphia, PA United States, 2-5 April 2022. Hoboken, NJ United States: John Wiley and Sons. doi: 10.1096/fasebj.2022.36.S1.R5391
Using N-of-1 tests to identify responders to melatonin for sleep disturbance in Parkinson’s Disease
Nikles, J., Mitchell, G. K., Smith, S. S., McGree, J. M., McDonald, S., Poli, N., Senior, H., Tan, S., Dissanyaka, N., Ritchie, A. and O'Sullivan, J. D. (2021). Using N-of-1 tests to identify responders to melatonin for sleep disturbance in Parkinson’s Disease. Australian Clinical Trials Alliance conference, Sydney, NSW, Australia, November 2021.
Pourzinal, D., Yang, J. H., Byrne, G. J., O'Sullivan, J. D., Mitchell, L. K., McMahon, K. L., Copland, D. A. and Dissanayaka, N. N. W. (2020). Altered functional connectivity of the hippocampus in posterior-cortical subtype of cognitive impairment in Parkinson’s disease. Australian Society for Medical Research Queensland Postgraduate Student Conference, Online, 11 November 2020.
Forbes, E., Byrne, G. J., Yang, J. H. J., O'Sullivan, J., Copland, D. A., McMahon, K. L., Mitchell, L. K. and Dissanayaka, N. N. (2020). Anxiety disorders are associated with verbal memory impairment in patients with Parkinson’s disease without dementia. Herston Health Precinct Symposium 2020, Brisbane, QLD, Australia, 7-11 December 2020.
Defining atypical anxiety in Parkinson’s disease
Forbes, E., Byrne, G. J., Yang, J. H. J., O'Sullivan, J., Copland, D. A., McMahon, K. L., Mitchell, L. K. and Dissanayaka, N. N. (2020). Defining atypical anxiety in Parkinson’s disease. Herston Health Precinct Symposium 2020, Brisbane, QLD, Australia, 7-11 December 2020.
Identification and clinical characteristics of mild cognitive impairment in Parkinson's disease
Yang, J., Forbes, E., Pourzinal, D., McMahon, K., Copland, D., Byrne, G., O'Sullivan, J., Mitchell, L. and Dissanayaka, N. (2020). Identification and clinical characteristics of mild cognitive impairment in Parkinson's disease. Herston Health Precinct Symposium 2020, Brisbane, QLD, Australia, 7-11 December 2020.
Improving diagnosis and treatment of anxiety in Parkinson’s disease: IDATA-PD study update
Dissanayaka, N., Byrne, G. J., Mitchell, L. K., O'Sullivan, J. D., Padmassini, A., White, E. X., Yang, J. H. J., Forbes, E., Thangavelu, K., Au, T., Lehn, A., Adam, R. and Pachana, N. A. (2020). Improving diagnosis and treatment of anxiety in Parkinson’s disease: IDATA-PD study update. Herston Health Precinct Symposium 2020, Brisbane, QLD Australia, 7-11 December 2020.
Yang, J., Copland, D., McMahon, K., Byrne, G., O'Sullivan, J. and Dissanayaka, N. (2020). Neural correlates of semantic fluency deficits in Parkinson’s disease patients with mild cognitive impairment. Herston Health Precinct Symposium 2020, Brisbane, QLD, Australia, 7-11 December 2020.
Therapy to Reduce dementia risk In Parkinson’s disease (TRIP): proof-of-concept protocol
Pourzinal, D., Bakker, A., Byrne, G. J., McMahon, K., O'Sullivan, J., Adam, R., Copland, D., Yang, J. H. J., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, Z. and Dissanayaka, N. (2020). Therapy to Reduce dementia risk In Parkinson’s disease (TRIP): proof-of-concept protocol. UQ Faculty of Medicine Higher Degree by Research Student Symposium, Brisbane, QLD Australia, 23-27 November 2020.
Therapy to reduce dementia risk in Parkinson’s disease (TRIP): proof-of-concept protocol
Pourzinal, D., Bakker, A., Byrne, G. J., McMahon, K., O'Sullivan, J., Adam, R., Copland, D., Yang, J. H. J., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, G. and Dissanayaka, N. (2020). Therapy to reduce dementia risk in Parkinson’s disease (TRIP): proof-of-concept protocol. Herston Health Precinct Symposium 2020, Brisbane, QLD Australia, 7-11 December 2020.
Anxiety is associated with verbal memory impairment in Parkinson’s disease
Forbes, E. J., Byrne, G. J., Yang, J. H., O'Sullivan, J., Copland, D. A., McMahon, K. L., Mitchell, L. M. and Dissanayaka, N. N. (2020). Anxiety is associated with verbal memory impairment in Parkinson’s disease. Australian Dementia Forum, Adelaide, SA, Australia, 31 May – 2 June 2020. Canberra, ACT, Australia: NHMRC National Institute for Dementia Research (NNIDR).
Anxiety is associated with verbal memory impairment in Parkinson’s disease
Forbes, E. J., Byrne, G. J., Yang, J. H. J., O'Sullivan, J., Copland, D. A., McMahon, K. L., Mitchell, L. and Dissanayaka, N. N. (2020). Anxiety is associated with verbal memory impairment in Parkinson’s disease. 5th Annual NHMRC National Institute for Dementia Research (NNIDR) Australian Dementia Forum, Adelaide, Australia, 31 May - 2 June 2020.
Anxiety is associated with verbal memory impairment in Parkinson’s disease
Forbes, E., Byrne, G.J., Yang, J.H.J., O'Sullivan, J., Copland, D.A., McMahon, K.L., Mitchell, L.K. and Dissanayaka, N.N. (2020). Anxiety is associated with verbal memory impairment in Parkinson’s disease. 53rd Australian Association of Gerontology (AAG) Conference, Online, 18-20 November 2020.
Emotional inhibition in Parkinson’s disease: a HD-EEG ERP study
Su, P., Hennessy, D., Au, T. R., Angwin, A. J., Iyer, K., Yang, J. H., Copland, D. A., O'Sullivan, J. D. and Dissanayaka, N. N. (2020). Emotional inhibition in Parkinson’s disease: a HD-EEG ERP study. Herston Health Precinct Symposium 2020, Brisbane, QLD Australia, 7-11 December 2020.
Identification and clinical characteristics of Mild Cognitive Impairment in Parkinson's disease
Yang, J., Forbes, E., Pourzinal, D., McMahon, K., Copland, D., Byrne, G., O'Sullivan, J., Mitchell, L. and Dissanayaka, N. (2020). Identification and clinical characteristics of Mild Cognitive Impairment in Parkinson's disease. Macquarie University BioNetwork 3rd Annual Research Symposium on Dementia, Online, 14-15 September 2020.
Identification and clinical characteristics of mild cognitive impairment in Parkinson’s disease
Yang, J.H., Forbes, E., Pourzinal, D., McMahon, K., Copland, D.A., Byrne, G.J., O'Sullivan, J., Mitchell, L. and Dissanayaka, N.N. (2020). Identification and clinical characteristics of mild cognitive impairment in Parkinson’s disease. MDS Virtual Congress 2020, Online, 12-16 September 2020.
Identification and clinical characteristics of mild cognitive impairment in Parkinson’s disease
Yang, Ji Hyun, Forbes, Elana, Pourzinal, Dana, McMahon, Katie, Copland, David, Byrne, Gerard, O'Sullivan, John, Mitchell, Leander and Dissanayaka, Nadeeka (2020). Identification and clinical characteristics of mild cognitive impairment in Parkinson’s disease. Australian Dementia Forum, Adelaide, SA, Australia, 31 May-2 June 2020. Canberra City, ACT, Australia: NHMRC National Institute for Dementia Research (NNIDR).
Pourzinal, D., Yang, J.H.J., Byrne, G.J., O'Sullivan, J., Mitchell, L., McMahon, K.L., Copland, D.A. and Dissanayaka, N.N. (2020). Investigating resting state functional connectivity in sub-phenotypes of Mild Cognitive Impairment in Parkinson’s disease. 5th Annual NHMRC National Institute for Dementia Research (NNIDR) Australian Dementia Forum, Adelaide, Australia, 31 May - 2 June 2020.
Neural correlates of semantic fluency deficits in Parkinson's Disease with mild cognitive impairment
Yang, J., Copland, D., McMahon, K., Byrne, G., O'Sullivan, J. and Dissanayaka, N.N. (2020). Neural correlates of semantic fluency deficits in Parkinson's Disease with mild cognitive impairment. MDS Virtual Congress 2020, Online, 12-16 September 2020.
Yang, J., Copland, D., McMahon, K., Byrne, G., O'Sullivan, J. and Dissanayaka, N. (2020). Neural correlates of semantic fluency deficits in Parkinson’s disease patients with mild cognitive impairment. Macquarie University BioNetwork 3rd Annual Research Symposium on Dementia, Online, 14-15 September 2020.
Yang, J. H. J., Copland, D. A., McMahon, K. L., Byrne, G. J., O'Sullivan, J. D. and Dissanayaka, N. N. (2020). Neural correlates of semantic fluency deficits in Parkinson’s disease patients with mild cognitive impairment. 5th Annual NHMRC National Institute for Dementia Research (NNIDR) Australian Dementia Forum, Adelaide, Australia, 31 May-2 June 2020.
Profiling atypical anxiety in Parkinson’s Disease
Forbes, E., Byrne, G.J., Yang, J.H.J., O'Sullivan, J., Copland, D.A., McMahon, K.L., Mitchell, L.K. and Dissanayaka, N.N. (2020). Profiling atypical anxiety in Parkinson’s Disease. MDS Virtual Congress 2020, Online, 12-16 September 2020.
Therapy to Reduce dementia risk In Parkinson’s disease (TRIP): Proof-of-concept protocol
Pourzinal, D., Bakker, A., Byrne, G., McMahon, K.L., O'Sullivan, J.D., Adam, R., Lehn, A., Copland, D., Yang, J.H., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, Z. and Dissanayaka, N.N.W. (2020). Therapy to Reduce dementia risk In Parkinson’s disease (TRIP): Proof-of-concept protocol. Macquarie University BioNetwork 3rd Annual Research Symposium on Dementia, Online, 14-15 September 2020.
Using cluster analysis to identify mild cognitive impairment phenotypes in Parkinson’s disease
Pourzinal, D., Yang, J.H.J., Byrne, G.J., O'Sullivan, J., Mitchell, L., McMahon, K.L., Copland, D.A. and Dissanayaka, N.N. (2020). Using cluster analysis to identify mild cognitive impairment phenotypes in Parkinson’s disease. 5th Annual NHMRC National Institute for Dementia Research (NNIDR) Australian Dementia Forum, Adelaide, Australia, 31 May - 2 June 2020.
Yang, J., McMahon, K., Copland, D. A., Byrne, G. J., O'Sullivan, J. D., Mitchell, L. and Dissanayaka, N. N. (2019). Identifying Altered Resting-State Networks in Parkinson’s disease Patients with Mild Cognitive Impairment. International Congress of Parkinson’s Disease and Movement Disorders, Nice, France, 22-26 September 2019. Hoboken, NJ United States: John Wiley & Sons.
Identifying altered resting-state network in Parkinson's disease with mild cognitive impairment
Yang, J. H., McMahon, K. L., Copland, D. A., Byrne, G. J., Mitchell, L. K., O'Sullivan, J. D. and Dissanayaka, N. N. W. (2019). Identifying altered resting-state network in Parkinson's disease with mild cognitive impairment. 23rd Annual Meeting of the Organisation for Human Brain Mapping, Rome, Italy, 9-13 June 2019.
Profiling atypical anxiety in Parkinson's disease
Forbes, E. J., Byrne, G. J., O'Sullivan, J. D., Yang, J. H. J., Marsh, R. and Dissanayaka, N. N. W. (2019). Profiling atypical anxiety in Parkinson's disease. University of Queensland Science Student Research Conference, Brisbane, QLD Australia, 12 October 2019.
Yang, J. H., McMahon, K. L., Copland, D. A., Byrne, G. J., Mitchell, L. K., O'Sullivan, J. D. and Dissanayaka, N. N. W. (2018). Altered network connectivity during resting state in Parkinson's disease patients with mild cognitive impairment as a marker for dementia. NNIDR Australian Dementia Forum, Sydney, NSW Australia, 4-5 June 2018.
Yang, J. H., McMahon, K. L., Copland, D. A., Byrne, G. J., Mitchell, L. K., O'Sullivan, J. D. and Dissanayaka, N. N. W. (2018). Altered network connectivity during resting state in Parkinson's disease patients with mild cognitive impairment as a marker for dementia. Imaging@Brisbane 2018, Brisbane, QLD Australia, 22-24 August 2018.
Yang, J. H., McMahon, K. L., Copland, D. A., Byrne, G. J., Mitchell, L. K., O'Sullivan, J. D. and Dissanayaka, N. N. W. (2018). Altered network connectivity during resting state in Parkinson's disease patients with mild cognitive impairment as a marker for dementia. 8th Australasian Cognitive Neuroscience Society Conference, Melbourne, VIC Australia, 22-25 November 2018.
Evans, Andrew, Fung, Victor S. C., O'Sullivan, John, Stell, Rick, White, Richard, Williams, David and Onuk, Koray (2018). Characteristics of advanced parkinson’s disease patients seen in movement disorder clinics – Australian results from the cross-sectional observe study. Annual Scientific Meeting of the Australian and New Zealand Association of Neurologists (ANZAN), Darwin, Australia, 29 May-1 June 2018 . London, United Kingdom: BMJ Group. doi: 10.1136/jnnp-2018-ANZAN.25
A case-control spectral analysis of sleep in Friedreich's Ataxia
Forbes, R., Smith, S. S., Ritchie, A., O'Sullivan, J. D. and Mantovani, S. (2017). A case-control spectral analysis of sleep in Friedreich's Ataxia. World Sleep 2017, Prague, Czech Republic, 7-11 October 2017. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.sleep.2017.11.611
Altered attention brain network in Parkinson’s disease with mild cognitive impairment
Yang, J. H., McMahon, K. L., Copland, D. A., Byrne, G. J., Toft, A. J. H., Mitchell, L. K., O'Sullivan, J. D. and Dissanayaka, N. N. W. (2017). Altered attention brain network in Parkinson’s disease with mild cognitive impairment. The Movement Disorder Society of Australia and New Zealand Scientific Conference, Gold Coast, QLD Australia, 22 September 2017.
Altered attention brain network in Parkinson’s disease with mild cognitive impairment
Yang, J.H., McMahon, K.L., Copland, D.A., Byrne, G.J., Toft, A.J.H., Mitchell, L.K., O'Sullivan, J.D. and Dissanayaka, N.N.W. (2017). Altered attention brain network in Parkinson’s disease with mild cognitive impairment. Centre for Advanced Imaging 4th Annual Symposium, Brisbane, Australia, 29 September 2017.
Altered attention brain network in Parkinson’s disease with mild cognitive impairment
Yang, J. H., McMahon, K . L., Copland, D. A., Byrne, G. J., Toft, A. J. H., Mitchell, L. K., O'Sullivan, J. D. and Dissanayaka, N. N. W. (2017). Altered attention brain network in Parkinson’s disease with mild cognitive impairment. International Congress of Parkinson's Disease and Movement Disorders, Vancouver, BC Canada, 4-8 June 2017. Hoboken, NJ United States: Wiley-Blackwell.
Anxiety in patients with cognitive impairment and Parkinson’s disease
Dissanayaka, N. N. W., Toft, A., Yang, J. H., Pachana, N., O'Sullivan, J., Mitchell, L., Copland, D. and Byrne, G. (2017). Anxiety in patients with cognitive impairment and Parkinson’s disease. NNIDR Australian Dementia Forum, Melbourne, VIC Australia, 15-17 October, 2017.
EEG Markers for Emotional Inhibition in Parkinson’s Disease
Dissanayaka, N., Hennessy, D., Au, T., Angwin, A., Yang, J., O’Sullivan, J. and Copland, D. (2017). EEG Markers for Emotional Inhibition in Parkinson’s Disease. International Congress of Parkinson's Disease and Movement Disorders, Vancouver, BC, Canada, 4-8 June 2017.
Electrophysiological markers for emotional and cognitive impairment in Parkinson’s disease
Dissanayaka, N., Au, T., Angwin, A., O’Sullivan, J., Byrne, G., Silburn, P., Marsh, R., Mellick, G. and Copland, D. (2017). Electrophysiological markers for emotional and cognitive impairment in Parkinson’s disease. International Congress of Parkinson's Disease and Movement Disorders, Vancouver, BC, Canada, 4-8 June 2017.
Yang, J. H., McMahon, K. L., Copland, D. A., Byrne, G. J., Toft, A. J. H., Rheinberger, T. J., Mitchell, L. K., O'Sullivan, J. D. and Dissanayaka, N. N. W. (2017). Impairments in functional networks linked to attentional deficits in mild cognitive impairment MCI in patients with Parkinson’s disease. 7th Australasian Cognitive Neuroscience Society Conference, Adelaide, SA Australia, 23-26 November 2017.
Dissanayaka, N. N. W., Pachana, N. A., O'Sullivan, J. D., Marsh, R., Silburn, P. A., White, E. X., Torbey, E., Pye, D., Mitchell, L. K., Yang, J. H., Toft, A. J., Au, T. R., Mellick, G. D., Copland, D. A. and Byrne, G. J. (2017). Improving Diagnosis and Treatment of Anxiety in Older Adults with Parkinson’s Disease (IDATA-PD STUDY). Psychology & Ageing Interest Group National Conference - Empowering older adults through psychology, Brisbane, QLD Australia, 6-7 October 2017.
Improving diagnosis and treatment of anxiety in Parkinson’s disease: IDATA-PD study
Dissanayaka, N., Pachana, N., O’Sullivan, J., Marsh, R., Silburn, P., White, E., Torbey, E., Pye, D., Mitchell, L., Mellick, G., Copland, D. and Byrne, G. (2017). Improving diagnosis and treatment of anxiety in Parkinson’s disease: IDATA-PD study. International Congress of Parkinson's Disease and Movement Disorders, Vancouver, BC, Canada, 4-8 June 2017. Hoboken, NJ United States: Wiley.
Toft, A., Yang, J., Byrne, G., O’Sullivan, J., Mitchell, L., Copland, D. and Dissanayaka, N. (2017). Investigating the Association between Anxiety and Cognitive Impairment in Parkinson’s Disease: A Descriptive Study. International Congress of Parkinson's Disease and Movement Disorders, Vancouver, BC Canada, 4-8 June 2017. Hoboken, NJ United States: Wiley-Blackwell.
Yang, J. H., McMahon, K. L., Copland, D. A., Byrne, G. J., Toft, A. J. H., Mitchell, L. K., O'Sullivan, J. D. and Dissanayaka, N. N. W. (2017). Understanding neural activation in semantic fluency in Parkinson’s disease with mild cognitive impairment. The Movement Disorder Society of Australia and New Zealand Scientific Conference, Gold Coast, QLD Australia, 22 September 2017.
Yang, J. H., McMahon, K. L., Copland, D. A., Byrne, G. J., Toft, A. J. H., Mitchell, L. K., O'Sullivan, J. D. and Dissanayaka, N. N. W. (2017). Understanding neural activation in semantic fluency in Parkinson’s disease with mild cognitive impairment. International Congress of Parkinson's Disease and Movement Disorders, Vancouver, BC Canada, 4-8 June 2017. Hoboken, NJ United States: Wiley-Blackwell.
Validity and reliability of anxiety and neuroticism assessment in Parkinson’s disease
Pachana, N., Torbey, E., O'Sullivan, J., Marsh, R., Silburn, P., Mellick, G., Byrne, G. and Dissanayaka, N. (2017). Validity and reliability of anxiety and neuroticism assessment in Parkinson’s disease. Stress and Anxiety Research Society 38th Annual Meeting 2017, Pokfulan, Hong Kong, 5-7 July 2017.
Emotional Inhibition In Parkinson’s Disease: An EEG Study
Hennessy, D., Au, T. R., Angwin, A. J., Yang, J. H., Copland, D. A., O'Sullivan, J. D. and Dissanayaka, N. N. W. (2016). Emotional Inhibition In Parkinson’s Disease: An EEG Study. 25th Annual RBWH Healthcare Symposium, Brisbane, QLD Australia, 12-16 September 2016.
Dissanayaka, N. N. W., Pachana, N. A., O'Sullivan, J. D., Marsh, R., Silburn, P. A., White, E. X., Torbey, E., Pye, D. and Mitchell, L. K. (2016). Improving Diagnosis and Treatment of Anxiety in Older Adults with Parkinson’s Disease (IDATA-PD STUDY). 25th Annual RBWH Healthcare Symposium, Brisbane, QLD Australia, 12-16 September 2016.
Improving Diagnosis and Treatment of Anxiety in Parkinson’s Disease: IDATA-PD study
Dissanayaka, N., Pachana, N., O'Sullivan, J., Marsh, R., Silburn, P., White, E., Torbey, E., Pye, D., Mitchell, L., Mellick, G., Copland, D. and Byrne, G. (2016). Improving Diagnosis and Treatment of Anxiety in Parkinson’s Disease: IDATA-PD study. Australia and New Zealand Association of Neurologists (ANZAN) Annual Scientic Meeting, Perth, WA Australia, 24-27 May 2016.
Mindfulness Intervention for Motor and Non-Motor Symptoms of Parkinson's Disease
Idu Jion, F., Harnett, P., Pachana, N. A., O’Sullivan, J. D., Marsh, R., Byrne, G. J. and Dissanayaka, N. N. W. (2016). Mindfulness Intervention for Motor and Non-Motor Symptoms of Parkinson's Disease. 25th Annual RBWH Healthcare Symposium, Brisbane, QLD Australia, 12-16 September 2016.
Mindfulness Intervention for motor and non-motor symptoms of Parkinson's disease
Idu Jion, F., Dissanayaka, N., Harnett, P., O'Sullivan, J. and Pachana, N. (2016). Mindfulness Intervention for motor and non-motor symptoms of Parkinson's disease. 7th Singapore International Parkinson’s Disease and Movement Disorders Symposium, Singapore, 29 September - 1 October 2016.
Tailored Cognitive Behaviour Therapy to Combat Anxiety in Parkinson’s Disease
Dissanayaka, N. N. W., Pye, D., Mitchell, L. K., Byrne, G. J., O'Sullivan, J. D., Marsh, R. and Pachana, N. A. (2016). Tailored Cognitive Behaviour Therapy to Combat Anxiety in Parkinson’s Disease. 25th Annual RBWH Healthcare Symposium, Brisbane, QLD Australia, 12-16 September 2016.
Tailored Cognitive Behaviour Therapy to combat anxiety in Parkinson’s disease
Dissanayaka, N., Pye, D., Mitchell, L., Byrne, G., O'Sullivan, J., Marsh, R. and Pachana, N. (2016). Tailored Cognitive Behaviour Therapy to combat anxiety in Parkinson’s disease. 8th World Congress of Behavioural and Cognitive Therapies, Melbourne, VIC Australia, 22-23 June 2016.
The association between anxiety and cognitive dysfunction in Parkinson’s disease
Toft, A., O'Sullivan, J., Marsh, R., Silburn, P., Mellick, G., Byrne, G. and Dissanayaka, N. N. W. (2016). The association between anxiety and cognitive dysfunction in Parkinson’s disease. 7th International Postgraduate Symposium in Biomedical Science, Brisbane, QLD, Australia, 31 October - 1 November, 2016.
Cognitive Behaviour Therapy for anxiety in Parkinson’s disease: Outcomes for patients and carers
Pye, D., Dissanayaka, N., Mitchell, L., O'Sullivan, J., Marsh, R., Byrne, G. and Pachana, N. (2015). Cognitive Behaviour Therapy for anxiety in Parkinson’s disease: Outcomes for patients and carers. RANZCP Faculty of Psychiatry of Old Age and APS Psychology and Ageing Special Interest Group Joint Conference, Adelaide, SA Australia, 26-28 November 2015.
Mindfulness for Parkinson’s disease: a qualitative study
Dissanayaka, N., Idu Jion, F., Harnett, P., O'Sullivan, J. and Pachana, N. (2015). Mindfulness for Parkinson’s disease: a qualitative study. 24th Annual RBWH Health Care Symposium, Brisbane, Australia, 12-16 October 2015.
Mindfulness to combat anxiety in people with Parkinson's disease
Pachana, N. A., Dissanayaka, N. N., Jion, F. I., Harnett, P. and O'Sullivan, J. (2015). Mindfulness to combat anxiety in people with Parkinson's disease. Balancing Cure with Care: Advances in Late Life Mental Health, 17th IPA International Congress, Berlin, Germany, 13-16 October 2015. Cambridge, United Kingdom: Cambridge University Press.
Mindfulness to combat anxiety in people with Parkinson’s disease
Dissanayaka, N., Idu Jion, F., Harnett, P., O'Sullivan, J. and Pachana, N. (2015). Mindfulness to combat anxiety in people with Parkinson’s disease. 17th International Psychogeriatric Association International Congress, Berlin, Germany, 13-16 October 2015.
Peripheral immune complement activation in neurodegenerative disease
Mantovani, S., Gordon, R., Ngo, S., Pfluger, C., O'Sullivan, J., Noakes, P., Henderson, R., McCombe, P. and Woodruff, T. (2015). Peripheral immune complement activation in neurodegenerative disease. 25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society, Cairns Australia, 23-27 August 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. doi: 10.1111/jnc.13188
Shaffer, J., Nguyen, G., Coulthard, A., Wong, A., O'Sullivan, J. and Reutens, D. (2015). Segmentation Test-Retest of Perfusion Computed Tomography-Obtained Blood-Brain Barrier in Prediction of Infarct Expansion Following Acute Ischaemic Stroke. Southern Regional Meeting of the American-Federation-for-Medical-Research, New Orleans, LA, United States, 26-28 February 2015. Philadelphia, United States: Lippincott Williams & Wilkins. doi: 10.1097/JIM.0000000000000146
Cognitive and Emotional processing in Parkinson’s disease
Dissanayaka, N., Au, T., Angwin, A., O'Sullivan, J., Byrne, G., Silburn, P., Marsh, R., Mellick, G. and Copland, D. (2014). Cognitive and Emotional processing in Parkinson’s disease. 12th International Conference on Cognitive Neurosicence, Brisbane, QLD Australia, 27-31 July 2014.
Dissanayaka, N., Au, T., Angwin, A., O'Sullivan, J., Byrne, G., Silburn, P., Marsh, R., Mellick, G. and Copland, D. (2014). Electrophysiological markers enhancing diagnostic accuracy of depression and cognitive dysfunction in Parkinson’s disease. 23rd Annual RBWH Health Care Symposium, Brisbane, Australia, 13-17 October 2014.
Negative biases and slow negative wave in Parkinson’s disease
Au, T., Angwin, A., Copland, D., O'Sullivan, J., Byrne, G., Silburn, P., Marsh, R., Mellick, G. and Dissanayaka, N. (2014). Negative biases and slow negative wave in Parkinson’s disease. 12th International Conference on Cognitive Neurosicence, Brisbane, QLD Australia, 27-31 July 2014.
Symptomatology and treatment of anxiety in Parkinson’s disease
White, E., Byrne, G., O'Sullivan, J., Marsh, R., Silburn, P., Pachana, N., Mellick, G., Copland, D. and Dissanayaka, N. (2014). Symptomatology and treatment of anxiety in Parkinson’s disease. In: School of Medicine, The University of Queensland Annual Student Symposium, Brisbane, QLD Australia, (). 2014.
Deep brain stimulation for DYT3 dystonia: A case report
Lehn, A. C., Airey, C. A., O'Sullivan, J. and Boyle, R. (2013). Deep brain stimulation for DYT3 dystonia: A case report. HOBOKEN: WILEY-BLACKWELL.
Clinical implications of impulse control disorders in Parkinson's disease
O'Sullivan, John and Dissanayaka, Nadeeka (2013). Clinical implications of impulse control disorders in Parkinson's disease. APSAD 2013: Australasian Professional Society on Alcohol and other Drugs Conference, Brisbane, Australia, 24-27 November 2013. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.
Drug-induced compulsive disorders: clinical, ethical and legal challenges
Carter, Adrian, O'Sullivan, John, Dissanayaka, Nadeeka, Bartlett, Francesca, Hall, Wayne and Bell, Peter (2013). Drug-induced compulsive disorders: clinical, ethical and legal challenges. Australasian Professional Society on Alcohol and other Drugs Conference, Brisbane, QLD Australia, 24-27 November 2013. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing Ltd.. doi: 10.1111/dar.12077
Emotional dysfunction in Parkinson’s disease
Dissanayaka, N., Au, T., Angwin, A., O’Sullivan, J., Byrne, G., Silburn, P., Marsh, R., Mellick, G. and Copland, D. (2013). Emotional dysfunction in Parkinson’s disease. 22nd Annual RBWH Health Care Symposium, Brisbane, Australia, 14-18 October 2013.
Dissanayaka, N., Au, T., Angwin, A., O’Sullivan, J., Byrne, G., Silburn, P., Marsh, R., Mellick, G. and Copland, D. (2013). Emotional processing in Parkinson's disease and anxiety: an EEG study of visual affective word processing. BaCI 2013: First International Conference on Basic and Clinical Multimodal Imaging, Geneva, Switzerland, 5-8 September, 2013. Thousand Oaks, CA, United States: Sage Publications. doi: 10.1177/1550059413507209
Identifying EEG markers associated with anxiety in Parkinson's disease: late positive potential
Dissanayaka, N. N., Au, T., Angwin, A., Copland, D., O'Sullivan, J., Byrne, G. J., Marsh, R., Mellick, G. and Silburn, P. A. (2013). Identifying EEG markers associated with anxiety in Parkinson's disease: late positive potential. MDS 2013: 17th International Congress of Parkinson’s Disease and Movement Disorders, Sydney, NSW, Australia, 16-20 June, 2013. Hoboken, NJ, United States: John Wiley & Sons. doi: 10.1002/mds.25605
Patient perspectives on treatment-induced impulse control disorders
Carter, Adrian, Bell, Peter, Diezel, Helene, Dissanayaka, Nadeeka, O'Sullivan, John and Hall, Wayne (2013). Patient perspectives on treatment-induced impulse control disorders. Australasian Professional Society on Alcohol and other Drugs Conference, Brisbane, QLD Australia, 24-27 November 2013. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing Ltd.. doi: 10.1111/dar.12077
Dissanayaka, N., Au, T., Angwin, A., Copland, D., O’Sullivan, J., Byrne, G., Marsh, R., Mellick, G. and Silburn, P. (2012). Abnormal event related brain potentials generated while processing emotional information in anxious Parkinson’s disease patients. 8th International Congress on Mental Dysfunction and Other Non-Motor Features in Parkinson's Disease and Related Disorders, Berlin, Germany, 3-6 May 2012.
Abnormalities in emotional processing associated with anxiety in Parkinson’s disease
Dissanayaka, N., Au, T., Angwin, A., O’Sullivan, J., Byrne, G., Copland, D., Marsh, R., Mellick, G. and Silburn, P. (2012). Abnormalities in emotional processing associated with anxiety in Parkinson’s disease. Parkinson’s Australia National Conference, Brisbane, Australia, 13-14 July 2012.
CT perfusion and bilateral paramedian thalamic stroke due to Artery of Percheron occlusion
Sheikh, N., Wong, A., O'Sullivan, J., Blum, S., Airey, C., Dionisio, S., Mitchell, K., Coulthard, A., Cloustan, J., Groundwater, A., Rajah, T., Jhamb, A. and Henderson, R. (2012). CT perfusion and bilateral paramedian thalamic stroke due to Artery of Percheron occlusion. Annual Scientific Meeting and the 8th Smart Strokes Australasian Nursing and Allied Health Stroke Conference, Sydney, NSW, Australia, 29-31 August 2012. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1747-4930.2012.00907.x
Characterizing anxiety in Parkinson’s disease: clinical symptoms and neurophysiological markers
Dissanayaka, N., Au, T., Angwin, A., O’Sullivan, J., Byrne, G., Copland, D., Marsh, R., Mellick, G. and Silburn, P. (2012). Characterizing anxiety in Parkinson’s disease: clinical symptoms and neurophysiological markers. 21st Annual RBWH Health Care Symposium, Brisbane, Australia, 8-12 October 2012.
Depression and anxiety in Parkinson’s disease
Dissanayaka, N., Mellick, G., O’Sullivan, J. and Silburn, P. (2012). Depression and anxiety in Parkinson’s disease. Parkinson’s Australia National Conference, Brisbane, Australia, 13-14 July 2012.
Drug induced impulse control disorders: a prospectus for neuroethical analysis
Carter, A., Dissanayaka, N., O’Sullivan, J. and Hall, W. (2012). Drug induced impulse control disorders: a prospectus for neuroethical analysis. Parkinson’s Australia National Conference, Brisbane, Australia, 13-14 July 2012.
Dissanayaka, Nadeeka, Au, Tiffany, Angwin, Anthony, Copland, David, O’Sullivan, John, Byrne, Gerard, Marsh, Rodney, Mellick, George and Silburn, Peter (2012). Neural correlates of emotional processing in Parkinson’s disease and the influence of affective disturbances. 3rd Australasian Cognitive Neuroscience Conference (ACNS 2012 ), Brisbane, Australia, 29 November - 2 December 2012. Lausanne, Switzerland: Frontiers Research Foundation. doi: 10.3389/conf.fnhum.2012.208.00140
Au, Tiffany, Angwin, Anthony, Copland, David, Mellick, George, O’Sullivan, John, Silburn, Peter, Byrne, Gerard and Dissanayaka, Nadeeka (2012). Neural mechanisms underlying emotional processing in healthy older adults: electrophysiological correlates of visual affective word processing. 3rd Australasian Cognitive Neuroscience Conference (ACNS 2012 ), Brisbane, Australia, 29 November - 2 December 2012. Lausanne, Switzerland: Frontiers Research Foundation. doi: 10.3389/conf.fnhum.2012.208.00121
Berkovic, S. F., Corbett, M. A., Schwake, M., Bahlo, M., Dibbens, L. M., Lin, M., Gandolfo, L., Vears, D., O'Sullivan, J., Robertson, T., Bayly, M. A., Gardner, A. E., Vlaar, A. M., Korenke, G. C., Bloem, B. R., de Coo, I. F., Verhagen, J. M. A, Lehesjoki, A. E., Saftig, P. and Gecz, J. (2011). A New Form of Progressive Myoclonus Epilepsy with Early Ataxia and Scoliosis Due to Mutation in the Golgi Protein Gosr2. 29th International Epilepsy Congress, Rome Italy, Aug 28-Sep 01, 2011. MALDEN: WILEY-BLACKWELL.
Dissanayaka, N., Angwin A., Copland, D., O’Sullivan, J., Byrne, G., Marsh, M., Mellick, G. and Silburn, P. (2011). Abnormal event related brain potentials generated while processing emotional information in anxious Parkinson’s disease patients. The Biannual Movement Disorder Society of Australia Conference, Melbourne, Australia, 8-10 September 2011.
Dissanayaka, Nadeeka, Au, Tiffany, Angwin, Anthony, Copland, David, O’Sullivan, John, Byrne, Gerard, Marsh, Rodney, Mellick, George and Silburn, Peter (2011). Abnormal event related brain potentials generated while processing emotional information in anxious Parkinson’s disease patients. 2nd Australasian Cognitive Neuroscience Conference, Sydney, Australia, 9-12 December 2011.
Dissanayaka, N., Angwin, A., Copland, D., O’Sullivan, J., Byrne, G., Marsh, R., Mellick, G. and Silburn, P. (2011). Abnormal event related brain potentials generated while processing emotional information in anxious Parkinson’s disease patients. 20th RBWH Healthcare Symposium, Brisbane, Australia, 10-14 October 2011.
Assessment methods and factors associated with depression in Parkinson's disease
Dissanayaka, Nadeeka N., O'Sullivan, John D., Silburn, Peter A. and Mellick, George D. (2011). Assessment methods and factors associated with depression in Parkinson's disease. 7th International Congress on Mental Dysfunction and other Non-Motor Features in Parkinsons Disease and Related Disorders, Barcelona, Spain, 9-12 December 2010. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.jns.2011.06.031
Factors associated with freezing of gait in Parkinson’s disease
Dissanayaka, N., O’Sullivan, J., Silburn, P. and Mellick, G. (2010). Factors associated with freezing of gait in Parkinson’s disease. 19th Annual RBWH Health Care Symposium, Brisbane, Australia, 11-15 October 2010.
Immune response in acute ischaemic stroke
Badve, Monica S., Yan, J., Hull, R., Henderson, Robert, O’Sullivan, John D., Read, Stephen J., Wong, Andrew A. and McCombe, Pamela (2010). Immune response in acute ischaemic stroke. ANZAN Annual Scientific Meeting 2010, -, 2010. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jocn.2010.07.064
Barwood, Caroline, Murdoch, Bruce, Whelan, Brooke-Mai, Lloyd, David, Riek, Stephan and O'Sullivan, John (2010). Repetitive Transcranial Magnetic Stimulation (rTMS) and sham modulation of language function in non-fluent aphasia 2 months post stimulation. AoA2010: 48th Academy of Aphasia Proceedings, Athens, Greece, 23-26 October, 2010. Amsterdam, Netherlands: Elsevier BV. doi: 10.1016/j.sbspro.2010.08.117
Risk factors for depression in Parkinson’s disease
Dissanayaka, N. N., O’Sullivan, J. D., Silburn, P. A. and Mellick, G. D. (2010). Risk factors for depression in Parkinson’s disease. 7th International Congress on Mental Dysfunctions and Other Non-motor Features in Parkinson’s Disease and Related Disorders, Barcelona, Spain, 9-12 December 2010.
O’Maley, Karen A., O’Sullivan, John D., Wollin, Judy and Barras, Michael (2009). The impact of an individualised medication information session on medication knowledge and quality of life of people with parkinson’s disease. Australian and New Zealand Association of Neurologists (ANZAN) 2008 Annual Scientific Meeting, Australia, 2008. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jocn.2008.07.043
Assessing depression in Parkinson’s disease
Dissanayaka, N. N. W., Sellbach, A., Matheson, S., Marsh, R., Silburn, P. A., O'Sullivan, J. D., Byrne, G. J. and Mellick, G. D. (2009). Assessing depression in Parkinson’s disease. 5th National Conference on Depression in Elderly., Sydney, Australia, 2009.
Risk factors for depression in Parkinson’s disease
Dissanayaka, N. N., Sellbach, A., Matheson, S., Marsh, R., Silburn, P. A., O'Sullivan, J. D., Byrne, G. J. and Mellick, G. D. (2009). Risk factors for depression in Parkinson’s disease. 1st Joint Conference of the APS Psychology and Ageing Interest Group, and the Royal Australian and New Zealand College of Psychiatrists Faculty of Psychiatry of Old Age, Gold Coast, Australia, 12-14 November 2009.
Risk factors for depression in Parkinson’s disease
Dissanayaka, N., Sellbach, A., Matheson, S., O'Sullivan, J., Silburn, P. A., Marsh, R., Byrne, G. and Mellick, G. (2009). Risk factors for depression in Parkinson’s disease. 18th Annual RBWH Health Care Symposium, Brisbane, Australia, October 2009.
What contributes to depression in Parkinson’s disease?
Dissanayaka, N. N. W., Silburn, P. A., O’Sullivan, J. D. and Mellick, J. D. (2009). What contributes to depression in Parkinson’s disease?. Australian Society for Medical Research Queensland Postgraduate Student Conference, Brisbane, Australia, 26 May 2009.
Is depression in Parkinson’s disease ‘organic’ or ‘reactive’
Dissanayaka, N., Silburn, P., O’Sullivan, J. and Mellick, G. (2008). Is depression in Parkinson’s disease ‘organic’ or ‘reactive’. Australian Society for Medical Research Queensland Postgraduate Student Conference, Brisbane, Australia, 29 May 2008.
Risk factors for depression in Parkinson’s disease
Dissanayaka, N., O’Sullivan, J., Silburn, P. and Mellick, G. (2008). Risk factors for depression in Parkinson’s disease. 6th International Congress on Mental Dysfunctions and Other Non-motor Features in Parkinson’s Disease, Dresden, Germany, 16-19 October 2008.
Dissanayaka, N., Silburn, P., O’Sullivan, J. and Mellick, G. (2007). A candidate gene study of the serotonin and dopamine transporter genes in relation to depression in Parkinson's disease.. 2007 Eskitis Institute Graduate Student Symposium, Brisbane, Australia, October, 2007.
Dissanayaka, N., Silburn, P., O’Sullivan, J. and Mellick G. (2007). A candidate gene study of the serotonin and dopamine transporter genes in relation to depression in Parkinson’s disease. 6th Australian Human Gene Mapping Conference, Brisbane, Australia, 29-31 August 2007.
Genetic and non-genetic determinants of depression in the setting of Parkinson's disease
Dissanayaka, N., Silburn, P., O’Sullivan, J. and Mellick, G. (2007). Genetic and non-genetic determinants of depression in the setting of Parkinson's disease. ASMR Queensland Postgraduate Medical Research Student Conference, Brisbane, QLD, Australia, 23 May, 2007.
Increased population of activated T cells in patients after acute ischemic stroke
Yan, J., Greer, J. M., Cavanagh, H., Henderson, R., O'Sullivan, J., Read, S., Etherington, K. and McCombe, P. A. (2007). Increased population of activated T cells in patients after acute ischemic stroke. 37th Annual Scientific Meeting of the Australasian Society for Immunology, Sydney, Australia, 2-6 December 2007.
What contributes to depression in the setting of Parkinson's disease?
Dissanayaka, N., Sellbach, A., Matheson, S., Marsh, R., Silburn, P., O’Sullivan, J., Byrne, G. and Mellick, G. (2007). What contributes to depression in the setting of Parkinson's disease?. 4th National Conference on Depression in the Elderly, Sydney, NSW, Australia, 28-29 June, 2007.
Assessing risk factors for depression in Parkinson’s disease
Dissanayaka, N., Selbach, A., Matheson, S., Marsh, R., Silburn, P. A., O'Sullivan, J. D., Byrne, G. J. and Mellick, G. D. (2006). Assessing risk factors for depression in Parkinson’s disease. 5th National Conference of Emerging Researchers in Aging, Sydney, Australia, 2006. Sydney, Australia: University of Sydney, Centre for Education and Research on Ageing.
Assessing the risk factors for depression in Parkinson's disease
Dissanayaka, N., Sellbach, A., Matheson, S., Marsh, R., Silburn, P., O’Sullivan, J., Byrne, G. and Mellick, G. (2006). Assessing the risk factors for depression in Parkinson's disease. ASMR Queensland Postgraduate Medical Research Student Conference, Brisbane, QLD, Australia, 26 May, 2006.
Dissanayaka, N., Sellbach, A., Matheson, S., Marsh, R., Silburn, P., O’Sullivan, J., Byrne, G. and Mellick, G. (2006). Regular exposure to pesticides is related to depression associated with Parkinson's Disease: evidence from two independent Australian samples. 5th International Congress on Mental Dysfunction in Parkinson's Disease, Amsterdam, Netherlands, 12-14 June, 2006. Camden, London, United Kingdom: Elsevier. doi: 10.1016/S1353-8020(07)70104-9
Dissanayaka, N., Sellbach, A., Matheson, S., Marsh, R., Silburn, P., O’Sullivan, J., Byrne, G. and Mellick, G. (2006). Regular exposure to pesticides is related to depression associated with Parkinson's disease: evidence from two independent Australian samples. 2006 Eskitis Institute Graduate Student Symposium, Brisbane, QLD, Australia, November, 2006.
Validity of three depression rating scales in Australian Parkinson's Disease patients
Dissanayaka, N., Sellbach, A., Matheson, S., Marsh, R., Silburn, P., O’Sullivan, J., Byrne, G. and Mellick, G. (2006). Validity of three depression rating scales in Australian Parkinson's Disease patients. 5th International Congress on Mental Dysfunction in Parkinson's Disease, Amsterdam, Netherlands, 12-14 June, 2006. Camden, London, United Kingdom: Elsevier. doi: 10.1016/S1353-8020(07)70108-6
Validity of three depression rating scales in Australian Parkinson's disease patients
Dissanayaka, N., Sellbach, A., Matheson, S., Marsh, R., Silburn, P., O’Sullivan, J., Byrne, G. and Mellick, G. (2006). Validity of three depression rating scales in Australian Parkinson's disease patients. 2006 Eskitis Institute Graduate Student Symposium, Brisbane, QLD, Australia, November, 2006.
Circadian blood pressure variation after acute stroke
Pandian, J., Wong, A., Lincoln, D., Davis, J., Henderson, R., O'Sullivan, J. and Read, S. (2005). Circadian blood pressure variation after acute stroke. 18th World Congress of Neurology, Sydney, Australia, 5-11 November 2005. Amsterdam, Netherlands: Elsevier .
Development of a patient knowledge questionnaire for botulinum toxin use in movement disorders
Schoffer, KL and O'Sullivan, JD (2005). Development of a patient knowledge questionnaire for botulinum toxin use in movement disorders. 18th World Congress of Neurology, Sydney Australia, Nov 05-11, 2005. AMSTERDAM: ELSEVIER SCIENCE BV.
Impact of depression on quality of life in people with Parkinson’s disease
Dissanayaka, N. N. W., Sellbach, A., O’Sullivan, J. D., Silburn, P. A. and Mellick, G. D. (2005). Impact of depression on quality of life in people with Parkinson’s disease. 4th National Conference of Emerging Researchers in Aging, Brisbane, 2005.
Risk factors and assessment methods for depression associated with Parkinson's disease
Dissanayaka, N. N. W., Deng, Y., Marsh, R., O’Sullivan, J. D., Silburn, P. A., Roberts, M. and Mellick, G. D. (2005). Risk factors and assessment methods for depression associated with Parkinson's disease. ASMR Queensland Postgraduate Medical Research Student Conference, Brisbane, QLD, Australia, 10 June, 2005.
Dissanayaka, N. N. W., Sellbach, A., O’Sullivan, J. D., Silburn, P. A. and Mellick, G. D. (2005). The impact of depression and motor disability on quality of life in patients suffering from Parkinson's disease. The University of Queensland School of Medicine Southern Clinical Division Post Graduate Student Conference, Brisbane, QLD, Australia, 2005.
O'Sullivan, JD, Turner, K, Marks, L and Lees, AJ (2002). Controlled trial of speech therapy and intra-parotid botulinum toxin for the treatment of salivary drooling in Parkinson's disease. 7th International Congress of Parkinsons Disease and Movement Disorders, Miami Florida, Nov 10-14, 2002. NEW YORK: WILEY-LISS.
Katzenschlager, R, Costa, D, Gerschlager, W, O'Sullivan, JD, Lees, AJ and Brown, P (2002). Dopamine transporter imaging with I-123-FP-CIT SPECT demonstrates marked presynaptic nigrostriatal dopaminergic deficit in orthostatic tremor. 7th International Congress of Parkinsons Disease and Movement Disorders, Miami Florida, Nov 10-14, 2002. NEW YORK: WILEY-LISS.
Drooling in Parkinson's disease: A novel speech and language therapy intervention
Marks, L., Turner, K., O'Sullivan, J., Deighton, B. and Lees, A. (2001). Drooling in Parkinson's disease: A novel speech and language therapy intervention.
(2023–2027) NHMRC MRFF Dementia, Ageing and Aged Care Mission
(2023–2026) Huntington's Australia Research Grant
Mining the gut microbiome to develop new treatments and biomarkers for Parkinson's disease
(2023–2025) Wesley Medical Research Ltd
Gilchrist Family Parkinson's Research Program
(2022–2025) Research Donation Generic
(2022–2025) Research Donation Generic
Validating Magnetic Resonance diagnosis in Parkinson's Disease
(2022–2025) Research Donation Generic
Evaluation of Tolebrutinib as a novel disease-modifying therapeutic for Parkinson's disease
(2022–2024) The Michael J Fox Foundation Therapeutic Pipeline Program
(2021–2023) University of Georgia
(2021–2023) The Michael J Fox Foundation for Parkinsons Research
Uncovering a novel therapeutic target to reduce dementia risk in Parkinson's disease
(2021–2022) Metro North Hospital and Health Service
Uncovering a novel therapeutic target to reduce dementia risk in Parkinson's disease (TRIP study)
(2021–2022) Metro North Hospital and Health Service
(2020–2025) Monash University
(2019–2022) Murdoch Childrens Research Institute
(2019–2022) The Michael J Fox Foundation for Parkinsons Research
(2018–2023) University of Sydney
Targeting peripheral inflammatory pathology in Parkinson's disease using repurposed drugs
(2018–2019) Wesley Medical Research Ltd
(2018–2019) Metro North Hospital and Health Service
Sleep measurements in Friedreich's ataxia, Huntington's disease patients and healthy volunteers
(2018) Wesley Medical Research Ltd
The Queensland Drug Repurposing Initiative
(2017–2023) Queensland Government Advance Queensland Innovation Partnerships
(2017–2019) Wesley Medical Research Ltd
Therapeutic switching of a licensed oncology drug to target neuropathology in Parkinson's disease
(2017–2019) The Cure Parkinson's Trust
Pharmacological Targeting of Proinflammatory Kinase Signalling in Parkinson's disease
(2016–2018) The Michael J Fox Foundation for Parkinsons Research
Cognitive behaviour therapy for anxiety in Parkinson's disease: outcomes for patients and caregivers
(2016–2017) Royal Brisbane and Women's Hospital Foundation
Complement activation as a therapeutic target and clinical biomarker for Parkinson's disease
(2015–2017) NHMRC Project Grant
Mindfulness therapy for depression, anxiety, motor and cognitive dysfunction in Parkinson's disease
(2015–2016) Royal Brisbane and Women's Hospital
(2014–2016) Royal Brisbane and Women's Hospital
(2013–2014) Royal Brisbane & Women's Hospital Research Foundation
Improving diagnostic methods of anxiety disorders in Parkinson's disease: Phase 2
(2012–2013) Royal Brisbane & Women's Hospital Research Foundation
Therapeutic Targeting of Complement C5a Receptors in Huntington's Disease
(2011–2013) NHMRC Project Grant
The evolution of cognitive deficits in Lewy body disorders and related degenerative diseases.
Doctor Philosophy — Associate Advisor
Other advisors:
(2023) Doctor Philosophy — Associate Advisor
Depression in Parkinson's disease: assessment methods and risk factors
(2008) Doctor Philosophy — Associate Advisor
Other advisors: